DK150478B - METHOD OF ANALOGY FOR THE PREPARATION OF N-ARYL-N- (4-PIPERIDYL) -ARYLACETAMIDE DERIVATIVES - Google Patents

METHOD OF ANALOGY FOR THE PREPARATION OF N-ARYL-N- (4-PIPERIDYL) -ARYLACETAMIDE DERIVATIVES Download PDF

Info

Publication number
DK150478B
DK150478B DK427876AA DK427876A DK150478B DK 150478 B DK150478 B DK 150478B DK 427876A A DK427876A A DK 427876AA DK 427876 A DK427876 A DK 427876A DK 150478 B DK150478 B DK 150478B
Authority
DK
Denmark
Prior art keywords
parts
piperidinyl
filtered
evaporated
acid
Prior art date
Application number
DK427876AA
Other languages
Danish (da)
Other versions
DK150478C (en
DK427876A (en
Inventor
Stefan Sanczuk
Hubert K Fr Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK427876A publication Critical patent/DK427876A/en
Priority to DK453484A priority Critical patent/DK153474C/en
Publication of DK150478B publication Critical patent/DK150478B/en
Application granted granted Critical
Publication of DK150478C publication Critical patent/DK150478C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Description

i 150478in 150478

Den foreliggende opfindelse angår en analogifremgangsmåde til fremstilling af N-aryl-N-(4-piperidyl)-arylacetamidderivater med den i indledningen til krav 1 angivne almene formel (I), eller farmaceutisk acceptable syreadditionssalte deraf, hvilken fremgangsmåde er ejendommelig ved det i krav l's kendetegnende del angivne. De omhandlede forbindelser er nyttige som antiarrhytmiske midler.The present invention relates to an analogous process for the preparation of N-aryl-N- (4-piperidyl) -arylacetamide derivatives of the general formula (I) set forth in the preamble of claim 1, or pharmaceutically acceptable acid addition salts thereof, which is characterized by the process of claim 1. 1's characteristic part. The present compounds are useful as antiarrhythmic agents.

Der kendes i forvejen nogle N-aryl-N-(4-piperidyl)amidderivater, som har analgetisk aktivitet. Et antal sådanne forbindelser kan findes i de følgende referencer: USA patentskrift nr. 3.164.600 og C.A., 77, 34349a (1972).Some N-aryl-N- (4-piperidyl) amide derivatives are known which have analgesic activity. A number of such compounds can be found in the following references: U.S. Patent No. 3,164,600 and C.A., 77, 34349a (1972).

Blandt andet afviger de ved fremgangsmåden ifølge den foreliggende opfindelse fremstillede antiarrhytmiske forbindelser fra sådanne kendte forbindelser med hensyn til naturen af arylacetamid-gruppen, som er bundet til 4-stillingen i piperidinkernen.Among other things, the antiarrhythmic compounds prepared by the process of the present invention differ from such known compounds as to the nature of the arylacetamide group attached to the 4-position of the piperidine nucleus.

Det er endvidere kendt fra USA patentskrift nr. 3.869.436, at visse N-phenyl- og N-alkanoylpiperidylderivater, der yderligere er substitueret med en amidgruppe på piperidinringen, besidder én eller flere af de følgende egenskaber: antioxotremovin aktivitet, hypotensiv aktivitet, antiinflamatorisk aktivitet eller CNS-akti-vitet. Det er ikke omtalt, at sådanne forbindelser skulle besidde antiarrhytmisk aktivitet, og det er specielt blevet påvist, at en foretrukken forbindelse ifølge nævnte patentskrift nemlig N-(l-[2-(3-indolyl)ethyl]-4-piperidyl)propionanilid er uden antiarrhytmisk aktivitet.It is further known from US Patent No. 3,869,436 that certain N-phenyl and N-alkanoylpiperidyl derivatives further substituted with an amide group on the piperidine ring possess one or more of the following properties: antioxotremovine activity, hypotensive activity, anti-inflammatory activity activity or CNS activity. It is not disclosed that such compounds should possess antiarrhythmic activity, and it has been shown in particular that a preferred compound of said patent namely N- (1- [2- (3-indolyl) ethyl] -4-piperidyl) propionanilide is without antiarrhythmic activity.

De hidtil ukendte N-aryl-N-(4-piperidyl)arylacetamidderivater, som fremstilles ved fremgangsmåden ifølge den foreliggende opfindelse, betegnes ved den følgende almene formel: sy·, , \_/ XN-C-CH2-ArThe novel N-aryl-N- (4-piperidyl) arylacetamide derivatives prepared by the process of the present invention are denoted by the following general formula: sy ·,, - / XN-C-CH 2 -Ar

Ar og de farmaceutisk acceptable syreadditionssalte deraf, hvori: L betegner hydrogen, C-^-C^alkyl, C3-C6cycloalkyl, C3-C6-cycloalkyl-C^-Cgalkyl eller C3-C6alkenyl,Ar and the pharmaceutically acceptable acid addition salts thereof, wherein: L represents hydrogen, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkyl-C 1 -C 6 alkyl or C 3 -C 6 alkenyl,

Ar betegner phenyl, mono- eller di-substitueret phenyl, py-ridyl eller 2-pyrimidyl, hvori enhver af substituenterne i den mono- eller di-substituerede phenyl uafhængigt af hinanden er halogen eller C-^-^galkyl, 2 150478Ar represents phenyl, mono- or di-substituted phenyl, pyridyl or 2-pyrimidyl, wherein each of the substituents in the mono- or di-substituted phenyl is independently halogen or C 1-6 alkyl,

Ar1 betegner phenyl, mono- eller di-substitueret phenyl eller 2-thienyl, hvori enhver af substituenterne i den monoeller di-substituerede phenyl uafhængigt af hinanden er halogen, C^-C^alkyl, hydroxy eller C^-Cgalkyloxy, og X betegner hydrogen eller C-^-Cgalkyloxymethyl, og under den forudsætning, at L er forskellig fra Cg-Cgcycloalkyl, når Ar og Ar1 begge er phenyl eller substitueret phenyl, og X er hydrogen.Ar 1 represents phenyl, mono- or di-substituted phenyl or 2-thienyl, wherein each of the substituents of the mono or di-substituted phenyl is independently halogen, C 1 -C 6 alkyl, hydroxy or C 1 -C 6 alkyloxy, and X represents hydrogen or C 1 -C 6 alkyloxymethyl, and assuming that L is different from C 8 -C 8 cycloalkyl when Ar and Ar 1 are both phenyl or substituted phenyl and X is hydrogen.

Når L betegner alkyl kan den være ligekædet eller forgrenet med fra 1 til 10 carbonatomer, som f.eks. methyl, ethyl, 1-methyl-ethyl, propyl, 1-methylpropyl, butyl, 2-methylbutyl, 1,1-dimethyle-thyl, pentyl, hexyl, heptyl eller decyl. Det i de foregående og i de efterfølgende definitioner anvendte udtryk "C-^-Cgalkyl" betyder ligekædede eller forgrenede alkylgrupper, som f.eks. methyl, ethyl, 2- methylethyl, propyl, butyl, pentyl eller hexyl. Udtrykket "C^-Cg-alkenyl" betyder alkenylgrupper som f.eks. 2-propenyl, 2-butenyl, 3- butenyl eller 2-pentenyl. Udtrykket "Cg-Cgcycloalkyl" betyder cycliske carbonhydridgrupper med fra 3 til 6 carbonatomer, som f.eks. cyclopropyl, cyclobutyl, cyclopentyl eller cyclohexyl. Udtrykket "halogen" er fælles for halogener med atomvægt mindre end 127, d.v.s. fluor, chlor, brom og iod.When L represents alkyl, it may be straight-chain or branched with from 1 to 10 carbon atoms, such as e.g. methyl, ethyl, 1-methylethyl, propyl, 1-methylpropyl, butyl, 2-methylbutyl, 1,1-dimethylethyl, pentyl, hexyl, heptyl or decyl. The term "C 1 -C 6 alkyl" used in the preceding and subsequent definitions means straight-chain or branched-chain alkyl groups, such as e.g. methyl, ethyl, 2-methylethyl, propyl, butyl, pentyl or hexyl. The term "C ^-Cg alkenyl" means alkenyl groups such as e.g. 2-propenyl, 2-butenyl, 3-butenyl or 2-pentenyl. The term "Cg-Cg cycloalkyl" means cyclic hydrocarbon groups having from 3 to 6 carbon atoms, such as e.g. cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. The term "halogen" is common to atomic halogens less than 127, i.e. fluorine, chlorine, bromine and iodine.

De omhandlede forbindelser med formlen (I), hvori Ar, Ar1 og X har den tidligere anførte betydning, og L er hydrogen, formel (I-a), fremstilles ud fra et piperidinderivat, som har den almene formel (IV), hvori Ar, Ar' og X har den tidligere anførte betydning, og Z betegner C^-Cgalkyloxycarbonyl, ved hydrolyse i surt eller basisk vandigt medium. Udgangsforbindelserne (IV) fås ved, at man acylerer forbindelserne med formlen (II) med et arylacetylhalogenid, som har den almene formel (III), fortrinsvis chloridet.The compounds of formula (I) wherein Ar, Ar 1 and X are as previously defined and L is hydrogen, formula (I a) is prepared from a piperidine derivative having the general formula (IV) wherein Ar, Ar 'and X are as previously defined and Z represents C 1 -C 6 alkyloxycarbonyl, by hydrolysis in acidic or basic aqueous medium. The starting compounds (IV) are obtained by acylating the compounds of formula (II) with an arylacetyl halide having the general formula (III), preferably the chloride.

x o Ζ-ΓΛ/ + halogen-C-CHj-Ar1 acyleringx o Ζ-ΓΛ / + halogen-C-CH 2 -Ar 1 acylation

'-' 'HH'-' 'HH

Ar (II) (III) oc ί i hydr°iyseAr (II) (III) and in hydride

Vc-CH.-Ar ^ L 2 (IV) JT\ ° \-' TJ-C-CH.-Ar1 (I-a) I 2Vc-CH.-Ar ^ L 2 (IV) JT \ ° \ - 'TJ-C-CH.-Ar1 (I-a) I 2

Ar 3 150478Ar 3 150478

Acyleringen af (II) med (III) kan udføres efter velkendte N-acy-leringsfremgangsmåder, f.eks. under omrøring og opvarmning under tilbagesvaling af reaktanterne sammen i et velegnet reaktionsinert organisk opløsningsmiddel, fortrinsvis i nærværelse af en passende base. Velegnede opløsningsmidler, som kan anvendes, omfatter f.eks. aromatiske carbonhydrider, som f.eks. benzen, methylbenzen eller dimethylbenzen, eller halogenerede carbonhydrider, såsom trichlorme-than. Passende baser omfatter f.eks. alkalimetalcarbonater eller -hydrogencarbonater, alkalimetalamider, såsom natriumamid, eller organiske baser, som f.eks. pyridin eller N,N-diethylethanamin.The acylation of (II) with (III) can be carried out by well-known N-acylation methods, e.g. with stirring and heating under reflux of the reactants together in a suitable reaction-inert organic solvent, preferably in the presence of a suitable base. Suitable solvents which may be used include, e.g. aromatic hydrocarbons such as e.g. benzene, methylbenzene or dimethylbenzene, or halogenated hydrocarbons such as trichloromethane. Suitable bases include e.g. alkali metal carbonates or hydrogen carbonates, alkali metal amides such as sodium amide, or organic bases such as e.g. pyridine or N, N-diethylethanamine.

Hydrolysen af forbindelse (IV) kan udføres surt under anvendelse af en stærk mineralsyre, f.eks. saltsyre, hydrogenbromidsyre eller svovlsyre, og alkalisk under anvendelse af alkoholisk base, f.eks. kaliumhydroxid i 2-propanol.The hydrolysis of compound (IV) can be carried out acidically using a strong mineral acid, e.g. hydrochloric acid, hydrobromic acid or sulfuric acid, and alkaline using alcoholic base, e.g. potassium hydroxide in 2-propanol.

Forbindelserne med formlen (I), hvori Ar, Ar^ og X har den tidligere anførte betydning, og L har den tidligere anførte betydning, men er forskellig fra hydrogen, og hvor L her betegnes ved L1,formel (I-b), kan fremstilles ved, at man indfører I^-substitu-enten i forbindelsen (I-a) ved N-alkylering.The compounds of formula (I) wherein Ar, Ar 1 and X are as previously defined and L is as previously defined but are different from hydrogen and where L is denoted by L 1, formula (Ib) can be prepared by , by introducing I 1 substituent either into the compound (I a) by N-alkylation.

Denne N-alkylering udføres ved, at man omsætter (I-a) med en forbindelse med formlen L1-Y, (V), hvori L·1 har den ovenfor anførte betydning, og Y er en reaktionsdygtig gruppe, fortrinsvis et halogenatom, eller en sulfonylgruppe, såsom methansulfonyl eller 4-me-thylbenzensulfonyl. Denne omsætning kan udføres på sædvanlig måde, f.eks. under omrøring og opvarmning under tilbagesvaling af reaktanterne sammen i et passende reaktionsinert organisk opløsningsmiddel, som f.eks. en lavere alkanol, f.eks. methanol, ethanol, propanol og butanol, et aromatisk carbonhydrid, f.eks. benzen, methylbenzen eller dimethylbenzen, en keton, f.eks. 4-methyl-2-pentanon, en ether, f.eks. 1,4-dioxan eller 1,1'-oxybisethan, Ν,Ν-dimethylformamid eller nitrobenzen. Til binding af syren, som frigøres i løbet af omsætningen, kan der tilsættes en passende base, som f.eks. natrium- eller kaliumcarbonat eller -hydrogencarbonat, eller en organisk base, som f.eks. Ν,Ν-diethylethanamin. En lille mængde af et alkalimetal-iodid, f.eks. kaliumiodid, kan tilsættes til forøgelse af omsætningshastigheden, især når den reaktive ester (V) er et chlorid eller bromid.This N-alkylation is carried out by reacting (Ia) with a compound of formula L1-Y, (V) wherein L · 1 is as defined above and Y is a reactive group, preferably a halogen atom, or a sulfonyl group. such as methanesulfonyl or 4-methylbenzenesulfonyl. This reaction may be carried out in the usual manner, e.g. with stirring and heating under reflux of the reactants together in a suitable reaction-inert organic solvent, e.g. a lower alkanol, e.g. methanol, ethanol, propanol and butanol, an aromatic hydrocarbon, e.g. benzene, methylbenzene or dimethylbenzene, a ketone, e.g. 4-methyl-2-pentanone, an ether, e.g. 1,4-dioxane or 1,1'-oxybisethane, Ν, Ν-dimethylformamide or nitrobenzene. To bind the acid which is released during the reaction, a suitable base may be added, e.g. sodium or potassium carbonate or hydrogen carbonate, or an organic base such as e.g. Ν, Ν-diethylethanamine. A small amount of an alkali metal iodide, e.g. potassium iodide, can be added to increase the rate of reaction, especially when the reactive ester (V) is a chloride or bromide.

Når L i forbindelserne (I) (herefter kaldet L ) betyder C1_1Qal-kyl, C3_6cycloalkyl eller C3_6cycloalkyl-C1_6alkyl, og når der til 4 150478 det til piperidin-nitrogenet forbundne carbonatom er bundet mindst 2 1 hydrogenatom, kan indføringen af L -gruppen lige så godt udføres ved katalytisk hydrogenering af en blanding af et til alkoholen L -OH svarende aldehyd eller keton, og en forbindelse med formlen (I-a) i nærværelse af en passende katalysator, som f.eks. palladium-på-trækul. Til forbedring af hydrogeneringens selektivitet kan der til blandingen sættes en lille mængde af en passende katalysatorgift, som f.eks. thiophen.When L in compounds (I) (hereinafter referred to as L) means C1-6alkyl, C3-6cycloalkyl or C3_6cycloalkyl-C1-6alkyl, and when at least 2 1 hydrogen atom is attached to the piperidine nitrogen, the introduction of the L group can be equally is well carried out by catalytic hydrogenation of a mixture of an aldehyde or ketone corresponding to the alcohol L -OH and a compound of formula (Ia) in the presence of a suitable catalyst such as e.g. palladium-on-charcoal. To improve the selectivity of hydrogenation, a small amount of a suitable catalyst poison may be added to the mixture, e.g. thiophene.

Endnu en fremgangsmåde til fremstilling af forbindelserne med formel (I-b) består i, at man N-acylerer en N-aryl-l-L^-4-piperidina-min, som har den almene formel (VII), med et arylacetylhalogenid, som har formlen (III), som ovenfor beskrevet for fremstillingen af (IV) ud fra (II) og (III).Yet another method of preparing the compounds of formula (Ib) consists in the N-acylation of an N-aryl-11L-4-piperidinamine having the general formula (VII) with an aryl acetyl halide having the formula (III), as described above for the preparation of (IV) from (II) and (III).

ιΛ-Ν V + (III) _(I-b)ιΛ-Ν V + (III) _ (I-b)

Y_/fHY_ / fH

Ar (VII) Når Ar1 i forbindelserne (I-b) betyder en substitueret phe-nylgruppe med 1 eller 2 hydroxylgrupper som substituenter alene eller sammen med andre substituenter, er det velegnet at beskytte disse hydroxylgrupper i. de tilsvarende udgangsmaterialer (III) med en passende beskyttende gruppe, såsom lavere alkyloxycarbonyl, hvorved et tilsvarende derivat af (I-b) opnås, hvorfra den beskyttende gruppe let fjernes ved alkalisk hydrolyse under anvendelse af f.eks. fortyndet vandig base.Ar (VII) When Ar 1 in compounds (Ib) means a substituted phenyl group having 1 or 2 hydroxyl groups as substituents alone or together with other substituents, it is suitable to protect these hydroxyl groups in the corresponding starting materials (III) with a suitable protective group, such as lower alkyloxycarbonyl, whereby a corresponding derivative of (Ib) is obtained, from which the protecting group is readily removed by alkaline hydrolysis using e.g. diluted aqueous base.

De omhandlede forbindelser kan omdannes til den farmaceutisk acceptable syreadditionssaltform ved behandling med en passende syre, som f.eks. en uorganisk syre, såsom hydrogenhalogenidsyre, f.eks. saltsyre eller hydrogenbromidsyre, eller svovlsyre, salpetersyre eller phosphorsyre, eller en organisk syre, som f.eks. eddikesyre, propionsyre, glycolsyre, mælkesyre, pyrodruesyre, malonsyre, ravsyre, fumarsyre, maleinsyre, æblesyre, vinsyre, citronsyre, benzoesyre, kanelsyre, mandelsyre, methansulfonsyre, ethansulfonsyre, benzensulfonsyre, 4-methylbenzensulfonsyre, cyclohexansulfaminsyre, salicylsyre eller 4-amino-2-hydroxybenzoesyre. Omvendt kan saltformen omdannes ved behandling med alkali til den frie baseform.The present compounds can be converted to the pharmaceutically acceptable acid addition salt form by treatment with a suitable acid, such as e.g. an inorganic acid such as hydrogen halide acid, e.g. hydrochloric or hydrobromic acid, or sulfuric acid, nitric or phosphoric acid, or an organic acid such as e.g. acetic acid, propionic acid, glycolic acid, lactic acid, pyruvic acid, malonic acid, succinic acid, fumaric acid, maleic acid, malic acid, tartaric acid, citric acid, benzoic acid, cinnamic acid, almond acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, 4-methylbenzenesulfonic acid, 4-methylbenzenesulfonic acid hydroxybenzoic. Conversely, the salt form can be converted by treatment with alkali to the free base form.

5 1504785 150478

De som udgangsmaterialer i de foregående fremgangsmåder anvendte mellemprodukter, hvoraf et antal er velkendte forbindelser, kan fremstilles som følger:The intermediates used as starting materials in the foregoing processes, a number of which are well-known compounds, can be prepared as follows:

Mellemprodukterne med den almene formel (II), hvori X betyder hydrogen, (Il-a), opnås bekvemt som følger. En 4-piperidinon, som har formlen (VIII), hvori der i 1-stillingen sidder den beskyttende alkyloxycarbonylgruppe Z, underkastes en kondensationsomsætning med en arylamin (IX), f.eks. under omrøring og opvarmning under tilbagesvaling af reaktanterne under azeotropisk vandfjernelse i et passende organisk opløsningsmiddel, fortrinsvis et aromatisk carbonhydrid, såsom benzen, methylbenzen eller dimethylbenzen, i nærværelse af en passende syre, som f.eks. 4-methylbenzensulfonsyre, eddikesyre, saltsyre eller lignende. Den resulterende Schiff-base (X) reduceres derpå med et passende reduktionsmiddel, som f.eks. natriumborhydrid, eller ved katalytisk hydrogenering under anvendelse af f.eks. platinoxidkatalysator til opnåelse af den tilsvarende N-aryl-4-piperidinamin (Il-a).The intermediates of the general formula (II) wherein X is hydrogen, (II-a) are conveniently obtained as follows. A 4-piperidinone having the formula (VIII) wherein in the 1-position sits the protective alkyloxycarbonyl group Z is subjected to a condensation reaction with an arylamine (IX), e.g. with stirring and heating under reflux of the reactants under azeotropic water removal in a suitable organic solvent, preferably an aromatic hydrocarbon such as benzene, methylbenzene or dimethylbenzene, in the presence of a suitable acid such as e.g. 4-methylbenzenesulfonic acid, acetic acid, hydrochloric acid or the like. The resulting Schiff base (X) is then reduced with a suitable reducing agent such as e.g. sodium borohydride, or by catalytic hydrogenation using e.g. platinum oxide catalyst to give the corresponding N-aryl-4-piperidinamine (II-a).

De ovenstående omsætninger belyses tydeligere i den følgende skematiske opstilling: O + H2H-Ar _Z —N ^=M-Ar (VIII) (IX) (X)The above reactions are illustrated more clearly in the following schematic arrangement: O + H2H-Ar _Z -N ^ = M-Ar (VIII) (IX) (X)

NaBH.NaBH.

-i--Ϊ (Il-a)-i - Ϊ (Il-a)

Mellemprodukter med den almene formel (VII),.hvori X er hydrogen, (Vll-a), fremstilles bekvemt ud fra (Il-a), idet X er hydrogen, ved for det første hydrolyse af Z til opnåelse af en N-aryl-4-piperidinamin, med formlen (XI), og.derefter indføring af I^-substi-tuenten som tidligere beskrevet for fremstillingen af (I-b) ud fra (I-a).Intermediates of the general formula (VII) wherein X is hydrogen, (VII-a) are conveniently prepared from (II-a), X being hydrogen, by firstly hydrolysis of Z to give an N-aryl -4-piperidinamine, of formula (XI), followed by introduction of the I I substituent as previously described for the preparation of (Ib) from (Ia).

Når L1 i mellemprodukterne (VII-a) betyder en methylgruppe, (VII-a-1), kan de direkte opnås ved reduktion af et mellemprodukt (Il-a), hvori X er hydrogen, med et passende reduktionsmiddel, som f.eks. lithiumaluminiumhydrid. Disse omsætninger belyses i den følgende skematiske opstilling: 6 150478 _ Η ΗWhen L1 in the intermediates (VII-a) means a methyl group, (VII-a-1), they can be obtained directly by reduction of an intermediate (II-a) wherein X is hydrogen, with a suitable reducing agent, such as . lithium aluminum hydride. These turnovers are illustrated in the following schematic layout: 6 150478 _ Η Η

(II-a) hydrolyse χ ΗΜ V indfrtring ν l1-^ V(II-a) hydrolysis χ ΗΜ V introduction ν l1- ^ V

- V-Am ~Tf~Li * \-AH- V-Am ~ Tf ~ Li * \ -AH

Ir IIr I

A Ar (XI) (Vll-a) ‘Ci-e^i’-o-'-OL CH3-Q^A Ar (XI) (Vll-a) 'Ci-e ^ i'-o -'- OL CH3-Q ^

Ir Ir (Il-a) (VII-a-1)Ir Ir (Il-a) (VII-a-1)

Mellemprodukterne med de almene formler (II) og (VII), hvori X betyder C^-Cgalkoxymethyl, henholdsvis (II-c) og (VII-c), kan fremstilles, som følger: l-phenylmethyl-4-piperidinon omsættes med en passende aryl-amin og et alkalimetalcyanid, f.eks. kaliumcyanid, i et vandigt organisk carboxylsyresystem, såsom eddikesyre, eller i en vandig lavalkanol i nærværelse af en ækvivalent mængde af en uorganisk syre, såsom saltsyre, hvorved indføring af nitrilfunktionen og af aminfunktionen finder sted i 4-stillingen i piperidinkernen.The intermediates of the general formulas (II) and (VII), wherein X represents C 1 -C 6 alkoxymethyl, respectively (II-c) and (VII-c), can be prepared as follows: 1-phenylmethyl-4-piperidinone is reacted with a suitable aryl amine and an alkali metal cyanide, e.g. potassium cyanide, in an aqueous organic carboxylic acid system such as acetic acid, or in an aqueous low alkanol in the presence of an equivalent amount of an inorganic acid such as hydrochloric acid, whereby the nitrile function and the amine function take place at the 4-position in the piperidine nucleus.

Nitrilen omdannes til det tilsvarende amid ved sur hydrolyse.The nitrile is converted to the corresponding amide by acid hydrolysis.

Med fordel kan man anvende en koncentreret stærk vandig uorganisk syre til dette formål, såsom saltsyre, phosphorsyre eller fortrinsvis svovlsyre. Amidet hydrolyseres yderligere til opnåelse af den tilsvarende carboxylsyre ved anvendelse af velkendte amid-til-syre-hy-drolysefremgangsmåder, f.eks. ved behandling med en fortyndet stærk syre, f.eks. saltsyre eller svovlsyre, eller ved alkalisk hydrolyse linder anvendelse af en passende base, f.eks. natrium- eller kaliumhydroxid. Den således opnåede carboxylsyre omdannes atter til et metalsalt deraf, fortrinsvis natriumsaltet, ved omsætning med base, f.eks. med natriumhydroxid. Carboxylsyren behøver ikke nødvendigvis at blive isoleret eller renset, men kan anvendes som en rå blanding til fremstillingen af saltet, eller saltet kan opnås direkte ved alkalisk hydrolyse.Advantageously, a concentrated strong aqueous inorganic acid may be used for this purpose, such as hydrochloric acid, phosphoric acid or preferably sulfuric acid. The amide is further hydrolyzed to obtain the corresponding carboxylic acid using well known amide-to-acid hydrolysis methods, e.g. by treatment with a dilute strong acid, e.g. hydrochloric or sulfuric acid, or by alkaline hydrolysis relieves the use of a suitable base, e.g. sodium or potassium hydroxide. The carboxylic acid thus obtained is again converted to a metal salt thereof, preferably the sodium salt, by reaction with base, e.g. with sodium hydroxide. The carboxylic acid does not necessarily need to be isolated or purified, but can be used as a crude mixture for the preparation of the salt, or the salt can be obtained directly by alkaline hydrolysis.

Saltet omdannes derpå til den ønskede ester ved omsætning med en passende halogen-lavalkan i et passende opløsningsmiddel, som f.eks. hexamethylphosphortriamid.The salt is then converted to the desired ester by reaction with a suitable halo-lower alkane in a suitable solvent, such as e.g. hexamethylphosphorotriamide.

7 1504787 150478

Alternativt kan estrene fremstilles ved omdannelse af syren til et acylhalogenid på sædvanlig måde ved behandling med et passende halogeneringsmiddel, f.eks. med sulfinylchlorid, og omsætning af dette acylhalogenid med en passende lavalkanol eller simpelthen ved omsætning af syren med en passende alkohol i nærværelse af en syre.Alternatively, the esters may be prepared by converting the acid into an acyl halide in the usual manner by treatment with a suitable halogenating agent, e.g. with sulfinyl chloride, and reacting this acyl halide with a suitable lower alkanol or simply by reacting the acid with a suitable alcohol in the presence of an acid.

Esteren reduceres herefter med et passende reduktionsmiddel, som f.eks. natrium-dihydro-bi s-(2-methoxyethoxy)aluminat (Red-Al) i et passende organisk opløsningsmiddel, som f.eks. benzen, eller med lithiumborhydrid til opnåelse af en 4-piperidinmethanol. Denne underkastes derpå en O-alkyleringsomsætning med et passende alkyle-ringsmiddel. O-alkyleringstrinet kan udføres ved omsætning af pipe-ridinmethanolen med en passende halogen-lavalkan eller et passende dilavalkyl-sulfat i et passende organisk opløsningsmiddel, som f.eks. benzen, methylbenzen, dimethylbenzen eller tetrahydrofuran i nærværelse af et passende kvartært ammoniumsalt, såsom Ν,Ν,Ν-triethyl-benzenmethanaminiumchlorid til dannelse af den tilsvarende 4-pipe-ridinalkyloxymethylforbindelse. Eliminering af den beskyttende 1-phenylmethylgruppe heri giver en 4-(C1-C6alkyloxymethyl)-N-aryl-4-piperidinamin. Mellemprodukterne (II) og (VII) kan fremstilles ved indføring af (C1-Cg))alkyloxycarbonylgruppen henholdsvis L1-sub-stituenten i den således opnåede forbindelse efter de heri tidligere beskrevne fremgangsmåder.The ester is then reduced with a suitable reducing agent such as e.g. sodium dihydro-bi-s- (2-methoxyethoxy) aluminate (Red-Al) in a suitable organic solvent such as e.g. benzene, or with lithium borohydride to give a 4-piperidine methanol. This is then subjected to an O-alkylation reaction with a suitable alkylating agent. The O-alkylation step can be carried out by reacting the piperidine methanol with an appropriate halogen-lower alkane or an appropriate dilavalkyl sulfate in an appropriate organic solvent, such as e.g. benzene, methylbenzene, dimethylbenzene or tetrahydrofuran in the presence of an appropriate quaternary ammonium salt such as Ν, Ν, Ν-triethylbenzene methanaminium chloride to form the corresponding 4-pipe-ridinalkyloxymethyl compound. Elimination of the protective 1-phenylmethyl group herein gives a 4- (C1-C6alkyloxymethyl) -N-aryl-4-piperidinamine. The intermediates (II) and (VII) can be prepared by introducing the (C1-C8) alkyloxycarbonyl group or L1 substituent, respectively, into the compound thus obtained following the methods described herein.

Forbindelserne med den almene formel (I) og deres farmaceutisk acceptable syreadditionssalte udviser udmærkede antiarrhytmiske egenskaber og er således velegnede i normaliseringen af uregelmæssige cardiale rytmer.The compounds of general formula (I) and their pharmaceutically acceptable acid addition salts exhibit excellent antiarrhythmic properties and are thus well-suited for the normalization of irregular cardiac rhythms.

Den antiarrhytmiske virkning af de ifølge opfindelsen fremstillede forbindelser fremgår klart af det følgende eksperiment med hunde.The antiarrhythmic effect of the compounds of the invention is evident from the following experiment with dogs.

Testforsøget udføres under neuroleptanalgesia (1 ml pr. 10 kg legemsvægt af fentanyl (N-phenyl-N-[l-(2-phenyl-ethyl)-4-piperidyl]-propanamid (0,4 mg(ml) og droperidol (20 mg/ml) (l-[l-[4-(4-fluor-phenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-1,3-dihydro~2H-benzimidazol-2-on)).The test run is performed under neuroleptanalgesia (1 ml per 10 kg body weight of fentanyl (N-phenyl-N- [1- (2-phenyl-ethyl) -4-piperidyl] -propanamide (0.4 mg (ml) and droperidol (20 mg / ml) (1- [1- [4- (4-fluoro-phenyl) -4-oxobutyl] -1,2,3,6-tetrahydro-4-pyridyl] -1,3-dihydro-2H-benzimidazole 2-one)).

Omkring 16 timer efter underbindingen af den foranliggende nedadvendende gren af den venstre koronære arterie udviser hunde en multifokal ventrikulær arrhytmi.About 16 hours after the ligation of the anterior downward branch of the left coronary artery, dogs exhibit a multifocal ventricular arrhythmia.

150478 δ150478 δ

Testforbindelserne indgaves intravenøst efter en kontrolperiode på 30 minutter, og de følgende kriterier anvendtes: 0 : ingen virkning.The test compounds were administered intravenously after a control period of 30 minutes and the following criteria were used: 0: no effect.

+ : formindskelse i antallet af for tidlige slag og forøgelse i antallet af normale slag med mindst 30% sammenlignet med kontrolværdien.+: decrease in the number of premature strokes and increase in the number of normal strokes by at least 30% compared to the control value.

++ : formindskelse i antallet af for tidlige slag og forøgelse i antallet af normale slag med mindst 50% sammenlignet med kontrolværdien.++: decrease in the number of premature strokes and increase in the number of normal strokes by at least 50% compared to the control value.

+++ : normalisering af cardial rytme eller formind skelse i antallet af for tidlige slag og forøgelse i antallet af normale slag med mindst 75% sammenlignet med kontrolværdien.+++: normalization of cardiac rhythm or decrease in the number of premature beats and increase in the number of normal beats by at least 75% compared to the control value.

De i dette forsøg opnåede resultater er anført i de følgende ta-beller, som tjener til eksemplificering af de nyttige antiarrhyt-miske egenskaber af alle forbindelserne inden for rammerne af formel (I).The results obtained in this experiment are set forth in the following tables which serve to exemplify the useful antiarrhythmic properties of all the compounds within the scope of formula (I).

9 150478 ------[ bo i9 150478 ------ [bo i

φ < + + + + + Iφ <+ + + + + + I

vObO, + + + + + + + + 1 + IvObO, + + + + + + + + + 1 + I

mC C + + + + + + + + +i s ,5 « g Λ ^___ i :5 ή <mC C + + + + + + + + + i s, 5 «g Λ ^ ___ i: 5 ή <

e ω Ie ω I

Λ <? < JΛ <? <J

Μ ·Η W> -f- + I + + o o + + + + JΜ · Η W> -f- + I + + o o + + + + J

π)β£++ ++ + +π) β £ ++ ++ ++

-ri V ^ I-ri V ^ I

η M ' in Sη M ′ in S

5 -π - I5 -π - I

<, > ro I<,> ro I

........................1 n ! <D « H ! H S ® ^^—(r-l—lr-lr-l ΜΚΓί ί ·-* |lHnJ ουυυουο tdnj^i a ω-μ,οκκκκκκκ * * % i m h........................ 1 n! <D «H! H S ® ^^ - (r-l-lr-lr-l ΜΚΓί ί · - * | lHnJ ουυυουο tdnj ^ i a ω-µ, οκκκκκκκκ * *% i m h

» id id J»Id id J

& « M ___J& «M ___J

ο !ο!

I II I

0=0 «0 = 0 «

I Μ II Μ I

tC + -4 · >< ffiffiææ-Kiijææ æ κ κ [ j < ϋ6 ϋ° ϋ° ϋ° ο° ϋ° ϋ° ο" ϋ° ϋ° ϋ° ; J) !tC + -4 ·> <ffiffiææ-Kiijææ æ κ κ [j <ϋ6 ϋ ° ϋ ° ϋ ° ο ° ϋ ° ϋ ° ο "ϋ ° ϋ ° ϋ °; J)!

,Μ""" ...... ....... ' ' I, Μ "" "...... ....... '' I

i K W W B ffi ffi K w X Xn K. ! vOvOvOvDvOvDvDO O O 1 u O O O O O O O O n° ϋ ϋ .; < ,Ι,ΗΗΗΗΗΗΗi K W W B ffi ffi K w X Xn K.! vOvOvOvDvOvDvDO O O 1 u O O O O O O O O n ° ϋ ϋ .; <, Ι, ΗΗΗΗΗΗΗ

UOOOOOOO hOOUOOOOOOO hOO

I I I I I I I I 1 1 1 II I I I I I I I 1 1 1 I

+ ni to j --- ; K ; O i > CO V7 i H _ n- t- o + . r" v i- r- r- - J m JS + !E ^ K , iCiSiSi g « æ « Kco + is'* co μ n ! PQ ^^000++0+ UOU1 <; O O c c 0-0 d O ·η ·η --i j+ ni to j ---; K; O i> CO V7 i H _ n- t- o +. r "v i- r- r- - J m JS +! E ^ K, iCiSiSi g« æ «Kco + is' * co µ n! PQ ^^ 000 ++ 0 + UOU1 <; OO cc 0-0 d O · η · η --ij

£h i i i I i i i i_i 1 1 I£ h i i i i i i i i i_i 1 1 I

ίο 150478ίο 150478

--1........- 1 ----- "" —-—— . I--1 ........- 1 ----- "" —-——. IN

bD ! Φ Γ j. j. j. ++ +i ^c?+ + i + + + + + + , + + + + i+ 1 fflnS+ + + + + + + + + + + + + + ibD! Φ Γ j. j. j. ++ + i ^ c? ++ i +++ +++++++++++++++++++++++++++++

•Η +! I• Η +! IN

g in ig in i

+ -H--—----- I+ -H --—----- I

>1 bO ' 1 Μ -H bO 1 “ S + + } + + + + + ί + + + } J ί ί ! B-rf m. ! <0 > Μ !> 1 bO '1 Μ -H bO 1 “S ++} + + + + + ί +++} J ί ί! B-rf m.! <0> Μ!

---—--— ~ ' I---—--— ~ 'I

M ! s ! <-i g <u <u <d a tt)r-<r-(U ω ΓίΓίω ΓίΓΐΓ! ! (UMQiftinwinwuUSiSOUiOyU * Q) + }M! s! <-i g <u <u <d a tt) r- <r- (U ω ΓίΓίω ΓίΓΐΓ!! (UMQiftinwinwuUSiSOUiOyU * Q) +}

to Η Ito Η I

(0 id J(0 id J

λ ω ; 1 —— — ........——i «ο ! w j* !λ ω; 1 ——— ........—— i «ο! w j *!

vO + ++ IvO + ++ I

•Φ + + i « 53 53 . >° + ·+ ^ ! J* 53 a 53 Vj 53 Ό J° U 53 53 53 !• Φ ++ i «53 53. > ° + · + ^! J * 53 a 53 Vj 53 Ό J ° U 53 53 53!

~U Ο υ υ υ ϋ °t «ο «η 53 ϋ ϋ υ I~ U Ο υ υ υ ϋ ° t «ο« η 53 ϋ ϋ υ I

5 ι ' ' Λ "Τ u 53 53 Ο Λ Jp ^ «η »° -i ! < h υ υ υ * η ο υ ο υ 53° υ 53^ 53^ 53^ υ .5 ι '' Λ "Τ u 53 53 Ο Λ Jp ^« η »° -i! <H υ υ υ * η ο υ ο υ 53 ° υ 53 ^ 53 ^ 53 ^ υ.

'fNtOiftO'frtlfM'fUlfUUUlt1 j'fNtOiftO'frtlfM'fUlfUUUlt1 j

_ I_ I

Λ m m 53° k" !Λ m m 53 ° k "!

CO CO CO + vO .Λ ICO CO CO + vO .Λ I

'53 53 53 nO O U J'53 53 53 nO O U J

sD O O U--1->J IsD O O U - 1-> J I

+ + + + + + + + + V V ^ . -3^ ! 53 53 53 53 53 53 53 53 53λ n to υ « |+ + + + + + + + + V V ^. -3 ^! 53 53 53 53 53 53 53 53 53λ n to υ «|

- nOvOvOvOvOvOvO nO O ^ ^ ·** X j Κ I- nOvOvOvOvOvOvO nO O ^ ^ · ** X j Κ I

£ UOOUU-UUUUuooVUvoO I£ UOOUU-UUUUuooVUvoO I

^ I I I I I I I I I v_-- --- *-*'*_- ^ ι^ I I I I I I I I I v _-- --- * - * '* _- ^ ι

__r >—I ·—i -—I ·—« —· ·—* ·—· <—· 111 _Γ7 I ·—t I I__r> —I · —i -—I · - «- · · - * · - · <- · 111 _Γ7 I · —t I I

nUOOUUUUUsD'+^CQ'OOO ι t ι ι ι ι * ι ι ι * ~ * i r ι a 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 5: · tofococoto cocncocomrorocomrofo ! υυυυυυυυυυυυυυυυ ;nUOOUUUUUsD '+ ^ CQ'OOO ι t ι ι ι ι * ι ι ι * ~ * i r ι a 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 5: · tofococoto cocncocomrorocomrofo! υυυυυυυυυυυυυυυυ;

•r4 .«-( ·ιΗ -r-f ·Μ *r4 «Μ »*·« ·*-» ·Η ·Η ·τ4 ·Μ *Η tr? I• r4. «- (· ιΗ -r-f · Μ * r4« Μ »* ·« · * - »· Η · Η · τ4 · Μ * Η tr? I

ι ι ι ι ι ι ι I ι I I ι 1 ; 11 150478 u j? ^ to + + + + £ + + + + + + ! 5 ^ + + + + + + H®« gt--ι ι ι ι ι ι ι I ι I I ι 1; 11 150478 u j? ^ to ++++++++++++! 5 + + + + + + + H® «gt--

>t§ J*P> t§ J * P

ÆJX3-CÆJX3-C

U hS 4.U hS 4.

Ιβ'Η ε . + + + + •h D m + + + + + + + + fi ~ C-H CO (C C)Ιβ'Η ε. + + + + • h D m + + + + + + + + fi ~ C-H CO (C C)

UU

H ^H ^

HgHg

Hi G w w m w w £: r ·.Hi G w w m w w £: r ·.

O rtidrtrtrtOUO rtidrtrtrtOU

|IH ,Q .O ,0 .Ο ,Ο O *5| IH, Q .O, 0.Ο, Ο O * 5

Q) + - UQ) + - U

tn h s-* <0 (0 Λ tn ·+ + + K K ..Ό w rf vB O U v£> - w u u > υtn h s- * <0 (0 Λ tn · + + + K K ..Ό w rf vB O U v £> - w u u> υ

h νθ i i jJ0 Ih νθ i i jJ0 I

<* Π to co + CO<* Π to co + CO

I K ffi u >n m KI K ffi u> n m K

h υ υ ο E κ υh υ υ ο E κ υ

I I I I vO VO II I I I VO VO I

+ co + co O U co to co+ co + co O U co to co

w Kw K

sO vOsO vO

υ υυ υ

I II I

r}t + + -Φ CO COr} t ++ -Φ CO CO

K μΠ il] iC CO COK μΠ il] iC CO CO

vO vO vO sO + iEvO vO vO sO + iE

* υ ο υ υ υ υ % i I I I v>· «w-* Ifj ·"-< r-1 F-t rH I I Hh ο υ υ υ vo so I II I « * >°* υ ο υ υ υ υ% i I I I v> · «w- * Ifj ·" - <r-1 F-t rH I I Hh ο υ υ υ vo so I II I «*> °

+ + CO c0 U+ + CO c0 U

t" c- in m tn in m + i-ηt „c- in m tn in m + i-η

KffiKWfficown i N N co co nJ n fs u ο ο υ υ c h; i i i i i i i 12 150478KffiKWfficown in N N co co nJ n fs u ο ο υ υ c h; i i i i i i i 12 150478

.......... 1 .....——— ..... 1 I.......... 1 .....——— ..... 1 I

JJ

b0 Jb0 J

rS ++ ++1rS ++ ++ 1

M £ 25 + + + + + + + + + + + + + IM £ 25 +++++++++++++

•HÆ & j• Hi & j

___ J___ J

ίί

W .η + + JW .η + + J

ο + ο + + ί + ΐ + ί ·ΐ + + ίί +1 >. m ,ο + ο + + ί + ΐ + ί · ΐ + + ίί +1>. m,

βτί ·» Jβτί · J

’ td > CO I'Td> CO I

-1______________________________——— —----- ------- --------- ' ' — — --i-1 ______________________________——— —----- ------- --------- '' - - --i

CO ^_C0 ^_C0 ICO ^ _C0 ^ _C0 I

M nf)UOOwt)U<nmtnOto ww 1 (D njnjdXrtrtrt i rH ffiKWOOj3»WÆrQjQOx,^j3 i η ε υ u υ iM nf) UOOwt) U <nmtnOto ww 1 (D njnjdXrtrtrt i rH ffiKWOOj3 »WÄrQjQOx, ^ j3 i η ε υ u υ i

0) U w w w I0) U w w w I

O IO I

I MH II MH I

<D + I<D + I

tn h i Λ (0 · Λ m ' _ i —-- . — .......... " — ' -.....i ^ } "< Q» Ey Q QQ QQQ „ f f l· -, f l· ! u υ υ W η u ·tn hi Λ (0 · Λ m '_ i —--. - .......... "-' -..... i ^}" <Q »Ey Q QQ QQQ„ ffl · - , fl ·! u υ υ W η u ·

vO ‘ I ' -£> · I IvO 'I' - £> · I I

U co + co U + co i _____ ____- ---------------- ------- ---1U co + co U + co i _____ ____- ---------------- ------- --- 1

"" I"" I

CO CO ICO CO I

te w j υ υ !te w j υ υ!

rjl + + C0 ^_C0 Irjl ++ C0 ^ _C0 I

i< K S S «0 ® Hr_. g—v 2;-=. £·=\ \ <, vOvOvOiC Offi^;=\2i=\ p^\ p \j \j \ <, .) υ υ υ ο ο \j/\y j «-Η rH rH | H | · υ υ υ no ® ® υ %o ιi <K S S «0 ® Hr_. g-v 2; - =. £ · = \ \ <, vOvOvOiC Offi ^; = \ 2i = \ p ^ \ p \ j \ j \ <,.) Υ υ υ ο ο \ j / \ y j «-Η rH rH | H | · Υ υ υ no ® ® υ% o ι

I ' I « , 1 * II 'I «, 1 * I

rJiTji'+COUU'^PO IrJiTji '+ COUU' ^ PO I

" 1 ------- --------- -- 1 I"1 ------- --------- - 1 I

CO ICO I

W ! Ό & ! c-UtN-j^. i— f— e— r— r— r— ι a +1° ® Vo ^ k w κ ffi w a k ! 1 «Π 3 ΐ a a s s ?W j 13 150478W! Ό &! UTN-C-j ^. i— f— e— r— r— r— ι a + 1 ° ® Vo ^ k w κ ffi w a k! 1 «Π 3 ΐ a a s s? W j 13 150478

bObO

<D X — <θ\ + + ^ g ω + + + — ' cog2 + + + + + + + + + + + + + -HÆi + + + + + + + + + + + + + S in -μ-Η >i__,___ Λ O to H-fi? μ·Η<<DX - <θ \ + + ^ g ω ++ + + - 'cog2 + + + + + + + + + + + + + -HÄi + + + + + + + + + + + + + S in -μ- Η> i __, ___ Λ O to H-fi? μ · Η <

(0 C tsO(0 C tsO

•h a; c + + + + μμκ+ + + + + + + + I+ + + + C'HiT) 10 >fsT _ o — N n-»• h a; c + + + + μμκ + + + + + + + + I + + + + C'HiT) 10> fsT _ o - N n- »

OISLAND

^ O^ O

. _- O ju a) o; m iu U v υ <!> v O riaimtom ® w · w « « .2ϋ 9 ynJnJriri ^ _ nj rt rt rt · «J V U S j o o o Q) U ΰ æ. _- O ju a) o; m iu U v υ <!> v O riaimtom ® w · w «« .2ϋ 9 ynJnJriri ^ _ nj rt rt rt · «J V U S j o o o Q) U ΰ æ

p ffi Op fi O

i) S ** Όi) S ** Ό

ta h Ota h O

nj (d Onj (d O

Λ ta β +^ x ^ tf ·ψ W tf tf Λ ffi Λ 'ί· x a jo a a j° to s o ®, O O o O ' u ^ m J, J, ffi J, Λ K aT ^ Em r' ?f ri S Κυυυυυυ U HvO vO1? ^ ^ , (Ό I I I I I I i [i°li°Ji O ' O to 'i1 co co 'tf* co ro u u tf v_* n ro •tf "tf "Φ -tfΛ ta β + ^ x ^ tf · ψ W tf tf Λ ffi Λ 'ί · xa jo aaj ° to so ®, OO o O' u ^ m J, J, ffi J, Λ K aT ^ Em r '? F ri S Κυυυυυυ U WHO vO1? ^ ^, (Ό I I I I I I i [i ° li ° Ji O 'O to' i1 co co 'tf * co ro u u tf v_ * n ro • tf "tf" Φ -tf

jj X X EG DS Xjj X X EG DS X

™ _ 2 i; 2 /- 2 Ά—J vO vO sO >D vO™ _ 2 i; 2 / - 2 Ά — J vO vO sO> D vO

/=* Λζ\ Γ*\Γ~ \f vT λ/λ / έ υ o o‘o o \\ VJ ^ J, J, J, J, 00000 1 i i i i tf Γ0 tf 'J' tf r— r- r— t— A f a" f f φΡψ ψ * a 1 *,= 14 150478 GO + ω t $ B + M3 “1 •Η X! e--/ = * Λζ \ Γ * \ Γ ~ \ f vT λ / λ / έ υ oo'oo \\ VJ ^ J, J, J, J, 00000 1 iiii tf Γ0 tf 'J' tf r— r- r— t— A fa "ff φΡψ ψ * a 1 *, = 14 150478 GO + ω t $ B + M3" 1 • Η X! e--

-P -H-P -H

Se tt> M -H <.See tt> M -H <.

(0 C Μ •Η Λ! £ , -P M C + CJ H ^ +(0 C Μ • Η Λ! £, -P M C + CJ H ^ +

<a > “V<a> “V

(M(M

u .u.

(U 1-1 Η ϋ η ε k(U 1-1 Η ϋ η ε k

<D M<D M

oisland

U I M-IU I M-I

< tu -P<tu -P

I CD i—IIn CD i — I

Γ0 (0 (0 a λ » υ °=4/=\ b - , X υ Ε υ ο tt '** £ υ Η Η f-Γ0 (0 (0 a λ »υ ° = 4 / = \ b -, X υ Ε υ ο tt '** £ υ Η Η f-

XX

Ρ1 , ΓΟ S ^ υ m ^ c ΕΗ 15 150478Ρ1, ΓΟ S ^ υ m ^ c ΕΗ 15 150478

Fremstilling af meliemprodukterManufacture of flour products

Eksempel 1Example 1

En blanding af 171,2 dele ethyl-4-oxQ-l-piperidincarboxylat, 159,5 dele 4-chlorbenzenamin, 1520 dele vandfri methylbenzen og nogle få krystaller 4-methylbenzensulfonsyre omrøres og holdes opvarmet under tilbagesvaling i 7 timer. (Reaktionsbeholderen er forsynet med en tilbagesvalingskondensator og vandudlader). Methylbenzenen fordampes, og den olieagtige remanens destilleres i vakuum til dannelse af 192 dele olieagtig ethyl-4-[ (4-chlorphenyl )imino] -1-piperidincarboxylat, kogepunkt 171 - 176 °C ved 0,4 mm tryk.A mixture of 171.2 parts of ethyl 4-oxo-1-piperidinecarboxylate, 159.5 parts of 4-chlorobenzeneamine, 1520 parts of anhydrous methylbenzene and a few crystals of 4-methylbenzenesulfonic acid is stirred and kept under reflux for 7 hours. (The reaction vessel is equipped with a reflux condenser and water discharger). The methylbenzene is evaporated and the oily residue is distilled in vacuo to give 192 parts of oily ethyl 4- [(4-chlorophenyl) imino] -1-piperidinecarboxylate, boiling point 171 - 176 ° C at 0.4 mm pressure.

Eksempel 2.Example 2.

Onder gentagelse af fremgangsmåden i Eksempel 1 og under anvendelse af en ækvivalent mængde af en passende arylamin i stedet for den deri anvendte 4-chlorbenzenamin opnås de følgende forbindelser: 0 1 /"V» .By repeating the procedure of Example 1 and using an equivalent amount of a suitable arylamine instead of the 4-chlorobenzeneamine used therein, the following compounds are obtained: 0 1 / "V".

CH3-CH2-0-C-N V=N-ArCH3-CH2-O-C-N V = N-Ar

Ar kogepunkt ved anført tryk 2-Cl-C-H 160-165 °C / 0,5-0,6 rom 64 2,6-(CH3)2-CgH3 142-145 °C / 0,01 mm 2-Cl,6-CH3-C6H3 195-200 °C / 0,2 mm 16 150478Ar boiling point at specified pressure 2-Cl-CH 160-165 ° C / 0.5-0.6 rom 64 2.6- (CH3) 2-CgH3 142-145 ° C / 0.01 mm 2-Cl, 6 -CH3-C6H3 195-200 ° C / 0.2 mm 16 150478

Ar kogepunkt ved anført tryk 4-F-C„H. 145-147 °C / 0,01 mm 6 4 3.4- (01)--0^- 190-200 °C / 0,02-0,03 mmAr boiling point at specified pressure 4-F-C „H. 145-147 ° C / 0.01 mm 6 4 3.4- (01) - 0 ° - 190-200 ° C / 0.02-0.03 mm

L· O OL · O O

3- C1-C-H. 165-170 °C / 0,01-0,02 mm O 4 4- Br-C-H, 180-183 °C / 0,1 mm 6 4 2.5- (Cl)2-C6H3 2-pyridinyl3- C1-C-H. 165-170 ° C / 0.01-0.02 mm 0 4 4- Br-C-H, 180-183 ° C / 0.1 mm 6 4 2.5- (Cl) 2-C6H3 2-pyridinyl

Eksempel 3.Example 3

En blanding af 171 dele ethyl-4-oxo-l-piperidincarboxylat, 162 dele 2,6-dichlorbenzenamin, 800 dele dimethylbenzen og 1 del 4-methylbenzensulfonsyre omrøres og holdes opvarmet under tilbagesvaling med vandudladning. Reaktionsblandingen inddampes til dannelse af 250 dele ethyl-4-[(2,6-dichlorphenyl)imino]-l-piperidincarboxylat som remanens.A mixture of 171 parts of ethyl 4-oxo-1-piperidinecarboxylate, 162 parts of 2,6-dichlorobenzamine, 800 parts of dimethylbenzene and 1 part of 4-methylbenzenesulfonic acid is stirred and kept heated under reflux with water discharge. The reaction mixture is evaporated to give 250 parts of ethyl 4 - [(2,6-dichlorophenyl) imino] -1-piperidinecarboxylate as residue.

Eksempel 4-Example 4-

En blanding af 34 dele ethyl-4-oxo-l-piperidincarboxylat, 20 dele 2-pyrimidinamin, 8 dråber eddikesyre og 90 dele methyl-benzen omrøres og opvarmes under tilbagesvaling i 28 timer med vandudladning. Reaktionsblandingen inddampes til dannelse af 50 dele ethyl-4-(2-pyrimidinylimino)-l-piperidincarboxylat som remanens.A mixture of 34 parts of ethyl 4-oxo-1-piperidinecarboxylate, 20 parts of 2-pyrimidinamine, 8 drops of acetic acid and 90 parts of methylbenzene is stirred and heated under reflux for 28 hours with water discharge. The reaction mixture is evaporated to give 50 parts of ethyl 4- (2-pyrimidinylimino) -1-piperidinecarboxylate as residue.

Eksempel s.Example p.

Til en varm opløsning af 192 dele ethyl-4-[(4-chlorphenyl)-imino]-1-piperidincarboxylat i 560 dele methanol sættes portionsvis 23,5 dele natriumborhydrid ved 50 °C og i løbet af en periode på 1 time. Efter fuldstændig tilsætning omrøres blandingen ved den samme temperatur i 2 timer. Methanolen afdampes. Den faste 17 150478 remanens opvarmes med 600 dele vand, og produktet ekstraheres med benzen. Ekstrakten tørres over magnesiumsulfat og inddampes.To a warm solution of 192 parts of ethyl 4 - [(4-chlorophenyl) imino] -1-piperidinecarboxylate in 560 parts of methanol is added portionwise 23.5 parts of sodium borohydride at 50 ° C and over a period of 1 hour. After complete addition, the mixture is stirred at the same temperature for 2 hours. The methanol is evaporated. The solid residue is heated with 600 parts of water and the product is extracted with benzene. The extract is dried over magnesium sulfate and evaporated.

Den olieagtige remanens størkner ved behandling med 2,2'-oxybis-propan. Faststoffet frafiltreres og tørres til dannelse af 122 dele ethyl-4-[(4-chlorphenyl)amino]-1-piperidincarboxylat, smeltepunkt 115 - 118 °C.The oily residue solidifies by treatment with 2,2'-oxybis-propane. The solid is filtered off and dried to give 122 parts of ethyl 4 - [(4-chlorophenyl) amino] -1-piperidinecarboxylate, mp 115-118 ° C.

Eksempel 6.Example 6

Efter fremgangsmåden i Eksempel 5 og under anvendelse af en ækvivalent mængde af et passende ethyl-4-arylimino-l-piperidin-carboxylat fremstilles de følgende forbindelser:Following the procedure of Example 5 and using an equivalent amount of an appropriate ethyl 4-arylimino-1-piperidine carboxylate, the following compounds are prepared:

OISLAND

II r~\/HII r ~ \ / H

CH3-CH2-0-C-W YCH3-CH2-0-C-W Y

ArYear

Ar smeltepunkt / kogepunktAr melting point / boiling point

2-Cl-CgH4 smp. 89-93 °C2-Cl-CgH 4 m.p. 89-93 ° C

2- Cl,6-CH3-CgH3 smp. 99,5 °C2- Cl, 6-CH3-CgH3 m.p. 99.5 ° C

4-F-CgH4 kp. 140-142 °C /0,01 mm4-F-CgH4 kp. 140-142 ° C / 0.01 mm

3.4- (Cl)2-CgH3 smp. 113,5 °C3.4- (Cl) 2-CgH3 m.p. 113.5 ° C

3- Cl-CgH4 smp. 72 °C3- Cl-CgH4 m.p. 72 ° C

4- Br-CgH4 smp. 116,5 °C4- Br-CgH 4 m.p. 116.5 ° C

2.5- (Cl)2-CgH3 smp. 107,2-110,3 °C2.5- (Cl) 2-CgH3 m.p. 107.2-110.3 ° C

2-pyrimidinyl Eksempel 7.2-Pyrimidinyl Example 7.

Til en omrørt og under tilbagesvaling opvarmet blanding af 18 150478 250 dele ethyl-4-[(2,6-dichlorphenyl)imino]-1-piperidin-carboxylat i 160 dele methanol og 160 dele 2-propanol sættes portionsvis 30 dele natriumborhydrid. Efter fuldførelse heraf fortsættes omrøring ved tilbagesvalingstemperatur i 1 time.To a stirred and refluxed mixture of 18 parts of ethyl 4 - [(2,6-dichlorophenyl) imino] -1-piperidine carboxylate in 160 parts of methanol and 160 parts of 2-propanol is added portionwise 30 parts of sodium borohydride. Upon completion, stirring is continued at reflux temperature for 1 hour.

Den varme reaktionsblanding hældes i vand, og produktet ekstra-heres med methylbenzen. Ekstrakten tørres og inddampes. Remanensen udkrystalliseres fra en blanding af 160 dele 2,2'-oxy-bispropan og 160 dele petroleumsether til dannelse af 96 dele ethyl-4-[(276-dichlorphenyl)amino]-1-piperidincarboxylat, smeltepunkt 107,2 - 116,6 °C.The hot reaction mixture is poured into water and the product is extracted with methylbenzene. The extract is dried and evaporated. The residue is crystallized from a mixture of 160 parts of 2,2'-oxy-bispropane and 160 parts of petroleum ether to give 96 parts of ethyl 4 - [(276-dichlorophenyl) amino] -1-piperidinecarboxylate, m.p. 107.2 - 116.6 ° C.

Eksempel 8.Example 8.

En blanding af 45 dele ethyl-4-[(2,6-dimethylphenyl)imino]-l-piperidincarboxylat, 0,3 dele platindioxid i 160 dele methanol hydrogeneres ved normalt tryk og ved en temperatur mellem 24 °C og 35 °C. Efter optagelse af den beregnede mængde hydrogen standses hydrogenering. Katalysatoren frafiltreres, og filtratet inddampes. Den olieagtige remanens destilleres til dannelse af 30 dele af den olieagtige frie base af ethyl-4-[(2,6-dimethyl-phenyl)amino]-1-piperidincarboxylat, kogepunkt 148 - 153 °C ved 0,01 mm tryk. Fra dette destillat fremstilles hydrochlorid-saltet på sædvanlig måde i 1,1'-oxybisethan. Det udfældede faste salt frafiltreres og tørres til dannelse af 28,5 dele ethyl-4-[(2,6-dimethylphenyl)amino]-l-piperidincarboxylat,hydrochlorid, smeltepunkt 195,5 °C.A mixture of 45 parts of ethyl 4 - [(2,6-dimethylphenyl) imino] -1-piperidinecarboxylate, 0.3 parts of platinum dioxide in 160 parts of methanol is hydrogenated at normal pressure and at a temperature between 24 ° C and 35 ° C. After uptake of the calculated amount of hydrogen, hydrogenation is stopped. The catalyst is filtered off and the filtrate is evaporated. The oily residue is distilled to give 30 parts of the oily free base of ethyl 4 - [(2,6-dimethyl-phenyl) amino] -1-piperidine carboxylate, bp 148 - 153 ° C at 0.01 mm pressure. From this distillate, the hydrochloride salt is prepared in the usual manner in 1,1'-oxybisethane. The precipitated solid salt is filtered off and dried to give 28.5 parts of ethyl 4 - [(2,6-dimethylphenyl) amino] -1-piperidinecarboxylate, hydrochloride, mp 195.5 ° C.

En blanding af 10 dele ethyl-4-[(2,6-dimethylphenyl)amino]-1-piperidincarboxylat og 135 dele hydrogenbromidsyreopløsning 48% omrøres ved en temperatur mellem 80 og 110 °C, indtil udviklingen af gasformig carbondioxid ophører (omkring 1 time).A mixture of 10 parts of ethyl 4 - [(2,6-dimethylphenyl) amino] -1-piperidinecarboxylate and 135 parts of hydrobromic acid solution 48% is stirred at a temperature between 80 and 110 ° C until the evolution of gaseous carbon dioxide ceases (about 1 hour ).

Den rødfarvede reaktionsblanding inddampes i vakuum. Remanensen optages i 56 dele methylbenzen, og methylbenzenen afdampes igen. Derpå gentages afdampning i en blanding af 24 dele 2-propanon og 40 dele methylbenzen. Den resulterende halvfaste remanens tritureres i 80 dele varm 2-propanon og ved afkøling udfældes det faste produkt. Dette frafiltreres, vaskes med små mængder 19 150478 absolut ethanol og 2-propanon efter hinanden og tørres til opnåelse af 13 dele N- (2,6-dimethylphenyl)-4-piperidinamin,dihydro-bromid, smeltepunkt 300 °C.The red-colored reaction mixture is evaporated in vacuo. The residue is taken up in 56 parts of methylbenzene and the methylbenzene is evaporated again. Evaporation is then repeated in a mixture of 24 parts of 2-propanone and 40 parts of methylbenzene. The resulting semi-solid residue is triturated in 80 parts of hot 2-propanone and upon cooling the solid product precipitates. This is filtered off, washed with small amounts of absolute ethanol and 2-propanone one after the other, and dried to give 13 parts of N- (2,6-dimethylphenyl) -4-piperidinamine, dihydrobromide, m.p. 300 ° C.

Eksempel 9.Example 9

Til en omrørt og afkølet (isbad) blanding af 165 dele ethyl-4-(2-pyridinylimino)-l-piperidincarboxylat og 736 dele methanol sættes portionsvis 29,5 dele natriumborhydrid (exotermisk omsætning) . Efter fuldførelse heraf fortsættes omrøring i 1 time og 30 minutter ved stuetemperatur. Reaktionsblandingen inddampes. Remanensen opslæmmes i 460 dele vand, og opslæmningen gøres sur med en koncentreret saltsyreopløsning. Det hele gøres alkalisk med ammoniumhydroxid, og produktet ekstraheres med methylbenzen. Ekstrakten tørres, filtreres og inddampes. Remanensen omdannes til oxalatsaltet i 2-propanol og 2,2'-oxybispropan. Saltet frafiltre-res, udvaskes med 2,2'-oxybispropan og tørres i vakuum til dannelse af 38 dele ethyl-4-(2-pyridinylamino)-1-piperidincarboxylat, oxalat.To a stirred and cooled (ice bath) mixture of 165 parts of ethyl 4- (2-pyridinylimino) -1-piperidinecarboxylate and 736 parts of methanol is added portionwise 29.5 parts of sodium borohydride (exothermic reaction). Upon completion, stirring is continued for 1 hour and 30 minutes at room temperature. The reaction mixture is evaporated. The residue is slurried in 460 parts of water and the slurry acidified with a concentrated hydrochloric acid solution. The whole is made alkaline with ammonium hydroxide and the product is extracted with methylbenzene. The extract is dried, filtered and evaporated. The residue is converted to the oxalate salt in 2-propanol and 2,2'-oxybispropane. The salt is filtered off, washed with 2,2'-oxybispropane and dried in vacuo to give 38 parts of ethyl 4- (2-pyridinylamino) -1-piperidinecarboxylate, oxalate.

En blanding af 90 dele ethyl-4-(2-pyridinylamino)-1-piperidincarboxylat, 90 dele kaliumhydroxid og 720 dele 2-propanol omrøres og opvarmes under tilbagesvaling i 2 dage. Reaktionsblandingen inddampes. 1000 dele vand sættes til remanensen, og produktet ekstraheres med dichlormethan. Ekstrakten tørres, filtreres og inddampes. Remanensen udkrystalliseres fra 2,2'-oxybispropan til dannelse af 13 dele N-(4-piperidinyl)-2-pyridinamin.A mixture of 90 parts of ethyl 4- (2-pyridinylamino) -1-piperidine carboxylate, 90 parts of potassium hydroxide and 720 parts of 2-propanol is stirred and heated under reflux for 2 days. The reaction mixture is evaporated. 1000 parts of water are added to the residue and the product is extracted with dichloromethane. The extract is dried, filtered and evaporated. The residue is crystallized from 2,2'-oxybispropane to form 13 parts of N- (4-piperidinyl) -2-pyridinamine.

Eksempel 10.Example 10.

En blanding af 7 dele ethyl-4-(2-pyrimidinylamino)-1-piperidincarboxylat og 120 dele hydrogenbromidsyreopløsning 48% omrøres og holdes opvarmet under tilbagesvaling i 2 timer. Reaktionsblandingen inddampes, og remanensen optages i vand. Det hele gøres alkalisk med en fortyndet natriumhydroxidopløsning under afkøling i et isbad. Produktet ekstraheres med dichlormethan. Ekstrakten tørres, filtreres og inddampes. Den faste 20 150478 remanens omrøres i 2,2’-oxybispropan. Produktet frafiltreres og omdannes til hydrochloridsaltet i 2-propanol. Saltet frafiltreres og udkrystalliseres fra ethanol til opnåelse af 2 dele N-(4-piperidinyl)-2-pyrimidinamin,dihydrochlorid/hemihydrat, smeltepunkt 268,5 °C.A mixture of 7 parts of ethyl 4- (2-pyrimidinylamino) -1-piperidinecarboxylate and 120 parts of hydrobromic acid solution is stirred 48% and kept under reflux for 2 hours. The reaction mixture is evaporated and the residue is taken up in water. The whole is made alkaline with a dilute sodium hydroxide solution while cooling in an ice bath. The product is extracted with dichloromethane. The extract is dried, filtered and evaporated. The solid residue is stirred in 2,2'-oxybispropane. The product is filtered off and converted to the hydrochloride salt in 2-propanol. The salt is filtered off and crystallized from ethanol to give 2 parts of N- (4-piperidinyl) -2-pyrimidinamine, dihydrochloride / hemihydrate, mp 268.5 ° C.

Eksempel 11.Example 11.

Til en omrørt opløsning af 58 dele ethy1-4-[(4-chlorphenyl)-amino]-1-piperidincarboxylat i 240 dele benzen sættes dråbevis en opløsning af 46,2 dele benzenacetylchlorid i 80 dele benzen ved en temperatur mellem 40 og 70 °C. Efter fuldførelse heraf omrøres det hele og holdes opvarmet under tilbagesvaling i 6 timer og 15 minutter. Reaktionsblandingen afkøles og filtreres. Filtratet udvaskes med vand, natriumhydrogencarbonatopløsning og vand efter hinanden, tørres derefter og inddampes i vakuum. Remanensen udkrystalliseres fra 1,1'-oxybisethan til dannelse af 47 dele ethy1-4-[N-(4-chlorphenyl)-N-(phenylacetyl)amino]-1-piperidincarboxylat, smeltepunkt 108 °C.To a stirred solution of 58 parts of ethyl 1- [- (4-chlorophenyl) amino] -1-piperidinecarboxylate in 240 parts of benzene is added dropwise a solution of 46.2 parts of benzene acetyl chloride in 80 parts of benzene at a temperature between 40 and 70 ° C. Upon completion, it is all stirred and kept under reflux for 6 hours and 15 minutes. The reaction mixture is cooled and filtered. The filtrate is washed with water, sodium bicarbonate solution and water one after the other, then dried and evaporated in vacuo. The residue is crystallized from 1,1'-oxybisethane to give 47 parts of ethyl 4- [N- (4-chlorophenyl) -N- (phenylacetyl) amino] -1-piperidinecarboxylate, m.p. 108 ° C.

Eksempel 12.Example 12.

Efter fremgangsmåden i Eksempel 11 og under anvendelse af ækvivalente mængder af henholdsvis et passende ethyl-4-aryl-amino-l-piperidincarboxylat og et passende arylacetylchlorid i stedet for det deri anvendte ethyl-4-[(4-chlorphenyl)amino]-1-piperidincarboxylat og benzenacetylchlorid fremstilles de følgende forbindelser: i ^~VHo CH--CH--0-C-N X || n \_/ XN-C-CH_-Ar I 2Following the procedure of Example 11 and using equivalent amounts of a suitable ethyl 4-aryl amino-1-piperidinecarboxylate and a suitable aryl acetyl chloride, respectively, in place of the ethyl 4 - [(4-chlorophenyl) amino] used therein -piperidinecarboxylate and benzeneacetyl chloride are prepared as follows: - VHo CH - CH - O-CN X || n \ _ / XN-C-CH_-Ar I 2

Ar 21 150478Ar 21 150478

Ar Ar1 smeltepunktAr Ar1 melting point

2,6-(CH_)2-thienyl 94,5 °C2,6- (CH 2) 2-thienyl 94.5 ° C

3 Z b 33 Z b 3

4-Cl-C6H4 2-thienyl 98,5 C4-C1-C6H4 2-thienyl 98.5 C

4-Cl-C^.H. 4-C1-C-.H. 127,5 °C4-Cl-C ^ .H. 4-C1-C-.H. 127.5 ° C

6 4 6 46 4 6 4

4-Cl-CcH. 4-CH--C^H. 112,5 C4-Cl-CCH. 4-CH - C ^ H. 112.5 ° C

6 4 3 6 46 4 3 6 4

2-C1-C.H. CcHc 123,0 C2-C1-C.H. CcHc 123.0 C

6 4 6 5 λ6 4 6 5 λ

2- Cl,6-CH0-CtH_ C-H- 114,5 C2- Cl, 6-CHO-CtH_ C-H- 114.5 C

3 6 3 6 5 03 6 3 6 5 0

4-F-CcIi. CcHc 82,0 C4-F-CCII. CcHc 82.0 C

6 4 6 56 4 6 5

3.4- (Cl)2“CgH3 CgH5 115,0 C3.4- (Cl) 2 "CgH3 CgH5 115.0 C

3- Cl-CgH4 CgHg 92,0 °C3- Cl-CgH 4 CgHg 92.0 ° C

4- Cl-C^-H. 4-F-CcH. 109,0 °C4- C1-C4 -H. 4-F-CCH. 109.0 ° C

6 4 6 4 ·6 4 6 4 ·

4-Cl-CcH. 3-CH--CJH. 121,5 C4-Cl-CCH. 3-CH - CJH. 121.5 ° C

6 4 3 6 46 4 3 6 4

4-Br-C,H. C-H- 114,5 C4-Br-C, H. C-H- 114.5 C

6 4 6 56 4 6 5

4-C1-C.H. 3-0CHo-C_H. 121,2 C4-C1-C.H. 3-0CHo-C_H. 121.2 ° C

6 4 3 6 46 4 3 6 4

4-Cl-CcH. 2-C1-CJH. 139,3 C4-Cl-CCH. 2-C1-CJH. 139.3 ° C

6 4 6 46 4 6 4

4-Cl-C,H. 3-Cl-CcH. 142,7 C4-Cl-C, H. 3-Cl-CCH. 142.7 ° C

6 4 6 4 '6 4 6 4 '

2-Cl,6-CH3-CgH3 4-Cl-CgH4 95,6 C2-Cl, 6-CH3-CgH3 4-Cl-CgH4 95.6 C

4-Cl-CgH4 2,6-(CH3)2-CgH3 120,4 °C4-Cl-CgH4 2.6- (CH3) 2-CgH3 120.4 ° C

3.4- (Cl)4-Cl-CcH. 136,9 °C3.4- (Cl) 4-Cl-CcH. 136.9 ° C

2 6 3 6 42 6 3 6 4

2.5- (Cl)2-CgH3 4-Cl-CgH4 107,0 C2.5- (Cl) 2-CgH3 4-Cl-CgH4 107.0 C

2.6- (Cl)2-CgH3 4-Cl-CgH4 140,0 °C2.6- (Cl) 2-CgH3 4-Cl-CgH4 140.0 ° C

Eksempel 13.Example 13

Til en omrørt opløsning af 8 dele ethyl-4-[(2,6-dimethyl-phenyl)amino]-1-piperidincarboxylat i 4 dele pyridin og 80 dele benzen sættes dråbevis 7,7 dele benzenacetylchlorid i 40 dele benzen. Efter fuldstændig tilsætning heraf opvarmes det hele til tilbagesvaling og omrøres ved tilbagesvalingstemperaturen i 3 timer og 45 minutter. Reaktionsblandingen afkøles og filtreres. Benzenfasen udvaskes med vand og derpå med natriumhydro-gencarbonatopløsning og med vand. Efter inddampning opnås en olieagtig remanens, som størkner ved triturering i 1,1'-oxy-bisethan til dannelse af 5 dele ethyl-4-[N-(2,6-dimethylphenyl)-N-(phenylacetyl)amino]-1-piperidincarboxylat, smeltepunkt 106 °C.To a stirred solution of 8 parts of ethyl 4 - [(2,6-dimethyl-phenyl) amino] -1-piperidinecarboxylate in 4 parts of pyridine and 80 parts of benzene is added dropwise 7.7 parts of benzene acetyl chloride in 40 parts of benzene. After complete addition, the whole is heated to reflux and stirred at the reflux temperature for 3 hours and 45 minutes. The reaction mixture is cooled and filtered. The benzene phase is washed out with water and then with sodium hydrogen carbonate solution and with water. After evaporation, an oily residue is obtained which solidifies by trituration in 1,1'-oxy-bisethane to give 5 parts of ethyl 4- [N- (2,6-dimethylphenyl) -N- (phenylacetyl) amino] -1- piperidine carboxylate, m.p. 106 ° C.

22 15047822 150478

Eksempel 14;Example 14;

Til en omrørt opløsning af 15 dele ethyl-4-[(4-chlorphenyl)-amino]-1-piperidincarboxylat, 5,4 dele Ν,Ν-diethylethanamin og 160 dele benzen sættes dråbevis 11,07 dele 4-methoxy-benzenacetyl-chlorid ved en temperatur mellem 32 og 40 °C. Efter fuldstændig tilsætning heraf omrøres det hele og holdes opvarmet under tilbagesvaling i 3 timer. Reaktionsblandingen afkøles og filtreres. Filtratet udvaskes med vand, natriumhydrogencarbonatopløsning og vand efter hinanden, tørres, filtreres og inddampes i vakuum.To a stirred solution of 15 parts of ethyl 4 - [(4-chlorophenyl) amino] -1-piperidinecarboxylate, 5.4 parts of Ν, Ν-diethylethanamine and 160 parts of benzene is added dropwise 11.07 parts of 4-methoxy-benzeneacetyl acid. chloride at a temperature between 32 and 40 ° C. After complete addition, the whole is stirred and kept under reflux for 3 hours. The reaction mixture is cooled and filtered. The filtrate is washed with water, sodium bicarbonate solution and water one after the other, dried, filtered and evaporated in vacuo.

Den olieagtige remanens udkrystalliseres fra en blanding af 56 dele l,l'-oxybisethan og 40 dele hexan. Det rå faste produkt frafiltreres og omkrystalliseres fra en blanding af benzen og l,l'-oxybisethan til dannelse af 3 dele ethyl-4- £N-(4-chlorphenyl) -N-[(4-methoxyphenyl)acetyl]amino | -1-piperidincarboxylat, smeltepunkt 137 °C.The oily residue is crystallized from a mixture of 56 parts of 1,1'-oxybisethane and 40 parts of hexane. The crude solid product is filtered off and recrystallized from a mixture of benzene and 1,1'-oxybisethane to give 3 parts of ethyl 4- 4- N- (4-chlorophenyl) -N - [(4-methoxyphenyl) acetyl] amino | -1-piperidinecarboxylate, mp 137 ° C.

Eksempel 15Example 15

Til en omrørt og under opvarmning tilbagesvalet blanding af 48 dele 1-(1-methylethyl)-4-piperidinon, 1 del 4-methylbenzen-sulfonsyre og 540 dele methylbenzen sættes dråbevis en opløsning af 30 dele benzenamin i 90 dele methylbenzen. Efter fuldførelse heraf omrøres det hele og holdes opvarmet under tilbagesvaling i 3 timer med vandudladning. Reaktionsblandingen inddampes til dannelse af 72 dele N-[1-(1-methylethyl)-4-piperidinyliden]-benzenamin som en remanens.To a stirred and refluxed mixture of 48 parts of 1- (1-methylethyl) -4-piperidinone, 1 part of 4-methylbenzenesulfonic acid and 540 parts of methylbenzene, a solution of 30 parts of benzenamine in 90 parts of methylbenzene is added dropwise. Upon completion, it is all stirred and kept under reflux for 3 hours with water discharge. The reaction mixture is evaporated to give 72 parts of N- [1- (1-methylethyl) -4-piperidinylidene] -benzenamine as a residue.

Til en omrørt og opvarmet (30-40 °C) opløsning af 72 dele N-[1-(1-methylethyl)-4-piperidinyliden]benzenamin i 480 dele methanol sættes portionsvis 20 dele natriumborhydrid. Efter fuldførelse heraf fortsættes omrøring natten over ved stuetemperatur. Reaktionsblandingen inddampes, og remanensen opløses i vand. Opløsningen ekstraheres med 4-methyl-2-pentanon. Ekstrakten udvaskes med vand og gøres sur med en fortyndet saltsyreopløsning. Den vandige syrefase gøres alkalisk med en fortyndet natriumhydroxidopløsning indtil pH-værdi = 9, og produktet ekstraheres med 4-methyl-2-pentanon. Ekstrakten udvaskes med vand, tørres, 23 150478 filtreres og inddampes. Remanensen destilleres (kogepunkt 135-140 °C ved 0,2 mm tryk), og destillatet udkrystalliseres fra petroleumsether til dannelse af 21 dele 1-(1-methylethyl)-N-phenyl-4-piperidinamin, smeltepunkt 69,3 °C.To a stirred and heated (30-40 ° C) solution of 72 parts of N- [1- (1-methylethyl) -4-piperidinylidene] benzenamine in 480 parts of methanol is added portionwise 20 parts of sodium borohydride. Upon completion, stirring is continued overnight at room temperature. The reaction mixture is evaporated and the residue is dissolved in water. The solution is extracted with 4-methyl-2-pentanone. The extract is washed with water and acidified with a dilute hydrochloric acid solution. The aqueous acid phase is made alkaline with a dilute sodium hydroxide solution until pH = 9 and the product is extracted with 4-methyl-2-pentanone. The extract is washed with water, dried, filtered and evaporated. The residue is distilled (bp 135-140 ° C at 0.2 mm pressure) and the distillate is crystallized from petroleum ether to give 21 parts of 1- (1-methylethyl) -N-phenyl-4-piperidinamine, mp 69.3 ° C.

Eksempel 16.Example 16.

En blanding af 19 dele 1-(phenylmethyl)-4-piperidinon, 11,8 dele 3-pyridinamin, 120 dele methylbenzen og et lille volumen 4-methylbenzensulfonsyre omrøres og holdes opvarmet under tilbagesvaling i 5 timer. (Reaktionsbeholderen er forsynet med tilbagesvalingskondensator og vandudlader). Efter udskillelse af den beregnede mængde vand inddampes opløsningsmidlet. Den olieagtige remanens opløses i 800 dele 2,2'-oxybispropan og inddampes igen til dannelse af 27 dele N-[1-(phenylmethyl)-4-piperidinyliden]-3-pyridinamin som en gulbrun olie.A mixture of 19 parts of 1- (phenylmethyl) -4-piperidinone, 11.8 parts of 3-pyridinamine, 120 parts of methylbenzene and a small volume of 4-methylbenzenesulfonic acid is stirred and kept under reflux for 5 hours. (The reaction vessel is equipped with reflux condenser and water discharge). After separating the calculated amount of water, the solvent is evaporated. The oily residue is dissolved in 800 parts of 2,2'-oxybispropane and again evaporated to give 27 parts of N- [1- (phenylmethyl) -4-piperidinylidene] -3-pyridinamine as a tan oil.

Til en omrørt opløsning af 27 dele N-[1-(phenylmethyl)-4-piperidinyliden]-3-pyridinamin i 40 dele ethanol sættes portionsvis 3,8 dele natriumborhydrid. Efter fuldført tilsætning opvarmes det hele til 50 °C. Opløsningsmidlet inddampes. Den olieagtige remanens opløses i 150 dele saltsyre IN og filtreres. Filtratet gøres alkalisk med ammoniumhydroxid og ekstraheres med methylbenzen. Det organiske lag tørres over magnesiumsulfat, filtreres og inddampes. Den faste remanens udvaskes med 2,2'-oxybispropan og tørres til dannelse af 14 dele N-[1-(phenylmethyl)-4-piperidinyl]-3-pyridinamin, smeltepunkt 131 - 133 °C, beige, amorft pulver.To a stirred solution of 27 parts of N- [1- (phenylmethyl) -4-piperidinylidene] -3-pyridinamine in 40 parts of ethanol is added portionwise 3.8 parts of sodium borohydride. After completion of the addition, the whole is heated to 50 ° C. The solvent is evaporated. The oily residue is dissolved in 150 parts hydrochloric acid 1N and filtered. The filtrate is made alkaline with ammonium hydroxide and extracted with methylbenzene. The organic layer is dried over magnesium sulfate, filtered and evaporated. The solid residue is washed with 2,2'-oxybispropane and dried to give 14 parts of N- [1- (phenylmethyl) -4-piperidinyl] -3-pyridinamine, mp 131-133 ° C, beige, amorphous powder.

En blanding af 20 dele N-[1-(phenylmethyl)-4-piperidinyl]-3-pyridinamin, 160 dele methanol, 30 dele vand og 12 dele af en koncentreret saltsyreopløsning hydrogeneres ved normalt tryk og ved en temperatur mellem 22 og 39 °C i nærværelse af 7 dele palladium-på-trækul katalysator 10%. Efter optagelse af den beregnede mængde hydrogen standses hydrogeneringen. Katalysatoren frafiltreres, og filtratet inddampes. Den olieagtige remanens opløses i vand. Opløsningen gøres alkalisk med ammoniumhydroxid, mættes med fast kaliumcarbonat og ekstraheres derpå med methylbenzen. Ekstrakten tørres over kaliumcarbonat og inddampes. Den 24 150478 faste remanens omkrystalliseres fra en blanding af 40 dele benzen og 32 dele l,lr-oxybisethan til dannelse af 3 dele N-(4-piperidinyl)-3-pyridinamin, smeltepunkt 127 - 129 °C.A mixture of 20 parts of N- [1- (phenylmethyl) -4-piperidinyl] -3-pyridinamine, 160 parts of methanol, 30 parts of water and 12 parts of a concentrated hydrochloric acid solution is hydrogenated at normal pressure and at a temperature between 22 and 39 ° C in the presence of 7 parts palladium-on-charcoal catalyst 10%. After taking up the calculated amount of hydrogen, the hydrogenation is stopped. The catalyst is filtered off and the filtrate is evaporated. Dissolve the oily residue in water. The solution is made alkaline with ammonium hydroxide, saturated with solid potassium carbonate and then extracted with methylbenzene. The extract is dried over potassium carbonate and evaporated. The solid residue is recrystallized from a mixture of 40 parts of benzene and 32 parts of 1,1-oxybisethane to give 3 parts of N- (4-piperidinyl) -3-pyridinamine, m.p. 127 - 129 ° C.

En blanding af 52 dele 2-brompropan , 19 dele N-(4- piperidinyl)-3-pyridinamin, 33,3 dele natriumcarbonat, 3 dele kaliumiodid og 720 dele 4-methyl-2-pentanon omrøres og holdes opvarmet under tilbagesvaling i 24 timer. Reaktionsblandingen afkøles og filtreres. Filtratet inddampes. Remanensen renses ved søjlechromatografi over silicagel under anvendelse af methanol som elueringsmiddel. De rene fraktioner samles, og eluerings-midlet afdampes. Remanensen udkrystalliseres fra 2,2'-oxybis-propan til dannelse af 1,5 dele N-[1-(1-methylethyl)-4-piperidinyl]-3-pyridinamin, smeltepunkt 100,7 °C.A mixture of 52 parts of 2-bromopropane, 19 parts of N- (4-piperidinyl) -3-pyridinamine, 33.3 parts of sodium carbonate, 3 parts of potassium iodide and 720 parts of 4-methyl-2-pentanone is stirred and kept under reflux for 24 hours. hours. The reaction mixture is cooled and filtered. The filtrate is evaporated. The residue is purified by column chromatography over silica gel using methanol as eluent. The pure fractions are collected and the eluent is evaporated. The residue is crystallized from 2,2'-oxybis-propane to give 1.5 parts of N- [1- (1-methylethyl) -4-piperidinyl] -3-pyridinamine, mp 100.7 ° C.

Eksempel 17.Example 17

Efter fremgangsmåden i ekssnpel 16 (sidste afsnit; og under anvendelse af ækvivalente mængder af henholdsvis et passende bromid og en passende 4-(arylamino)-4-X-piperidin som udgangsmaterialer og under udførelse af omsætningen i det anførte opløsningsmiddel opnås de følgende forbindelser i fri baseform eller efter behandling med saltsyre i hydrochloridsaltform: 150478 25 ^ o o o •ri a s c! 6. « M * J3 $ J2 S S § g .2 5 .2 5 6 _ja__- ϋ υ η °Following the procedure of Example 16 (last section), and using equivalent amounts of a suitable bromide and a suitable 4- (arylamino) -4-X-piperidine, respectively, as starting materials and in carrying out the reaction in the solvent mentioned, the following compounds are obtained. free base form or after treatment with hydrochloric acid in hydrochloric salt form: 150478 25 ^ ooo • ri asc! 6. «M * J3 $ J2 SS § g .2 5 .2 5 6 _ja __- ϋ υ η °

O O \J OO O \ J O

& O r- in o co R o *»··»©·» ω rj< to co m σ> co O' v tn -C ri v co "ΤΓ& O r- in o co R o * »··» © · »ω rj <to co m σ> co O 'v tn -C ri v co" ΤΓ

MM

OISLAND

UU

rHrh

fljflew

WW

d O 4) 0 4)d O 4) 0 4)

Qj tn in to tn ’d td ni <- id ni r-i y ·“ ^ g “ “ g ® n m (0 & x k a s k w a w n X S- <J--- lf) v°Qj tn in to tn 'd td ni <- id ni r-i y · "^ g" "g ® n m (0 & x k a s k w a w n X S- <J --- lf) v °

j -S .S .Sj -S .S .S

h ^ Γ?h ^ Γ?

<*< »r4 «Η (J<* <»R4« Η {J

SL L tn * Ύ »o λ α ft ό ·** ιι 'η ι , όSL L tn * Ύ »o λ α ft ό · ** ιι 'η ι, ό

to co U co cm Uto co U co cm U

όόοΙΙόόόοΙΙό

-, co CO-, co CO

* £ £ υ υ w *>w* 26 150478* £ £ υ υ w *> w * 26 150478

Eksempel 18Example 18

Til en omrørt blanding af 15 dele N- (4-chlorphenyl)-4-piperidinamin, 12 dele N,N-diethylethanamin i 130 dele benzen sættes dråbevis en opløsning af 10,3 dele 3-brom-l-propen i 70 dele benzen. Efter endt tilsætning omrøres det hele først i 20 timer og 30 minutter ved stuetemperatur og yderligere i 40 minutter ved tilbagesvalingstemperatur. Reaktionsblandingen afkøles, filtreres, og filtratet inddampes. Remanensen optages i 1,1'-oxybisethan og behandles med aktiveret trækul. Dette frafiltreres, og l,l'-oxybisethanen afdampes igen til dannelse af 2,9 dele N-(4-chlorphenyl)-1-(2-propenyl)-4-piperidinamin, smeltepunkt 90 °C.To a stirred mixture of 15 parts of N- (4-chlorophenyl) -4-piperidinamine, 12 parts of N, N-diethylethanamine in 130 parts of benzene is added dropwise a solution of 10.3 parts of 3-bromo-1-propene in 70 parts of benzene. . After the addition is complete, the whole is first stirred for 20 hours and 30 minutes at room temperature and further for 40 minutes at reflux temperature. The reaction mixture is cooled, filtered and the filtrate is evaporated. The residue is taken up in 1,1'-oxybisethane and treated with activated charcoal. This is filtered off and the 1,1'-oxybisethane is again evaporated to give 2.9 parts of N- (4-chlorophenyl) -1- (2-propenyl) -4-piperidinamine, m.p. 90 ° C.

Eksempel 19Example 19

Til en varm (omkring 40 °C) og omrørt blanding af 5 dele N-(2,6-dimethylphenyl)-4-piperidinamin, 5 dele natriumcarbonat, nogle få krystaller kaliumiodid i 120 dele benzen sættes dråbevis en opløsning af 5,1 dele 1-iodpropan i 80 dele benzen. Efter endt tilsætning fortsættes omrøring i 40 timer ved tilbagesvalingstemperatur. Reaktionsblandingen afkøles, og 50 dele vand tilsættes. Det organiske lag fraskilles og inddampes i vakuum. Den olieagtige remanens destilleres til dannelse af 10,2 dele N-(2,6-dimethylphenyl)-l-propyl-4-piperidinamin, kogepunkt 135 °C ved 0,2 mm tryk.To a hot (about 40 ° C) and stirred mixture of 5 parts of N- (2,6-dimethylphenyl) -4-piperidinamine, 5 parts of sodium carbonate, a few crystals of potassium iodide in 120 parts of benzene, dropwise a solution of 5.1 parts 1-iodopropane in 80 parts of benzene. After the addition is complete, stirring is continued for 40 hours at reflux temperature. The reaction mixture is cooled and 50 parts of water are added. The organic layer is separated and evaporated in vacuo. The oily residue is distilled to give 10.2 parts of N- (2,6-dimethylphenyl) -1-propyl-4-piperidinamine, boiling point 135 ° C at 0.2 mm pressure.

Eksempel 20Example 20

Til 0,5 dele af en opløsning af 2 dele thiophen i 40 dele ethanol sættes 2 dele cydopentanon, 5,5 dele N-(4-piperidinyl)-2-pyrimidinamin og 120 dele methanol. Det hele hydrogeneres ved normalt tryk og ved stuetemperatur med 2 dele palladium-på-trækul 10%. Efter at den beregnede mængde hydrogen er optaget, frafiltreres katalysatoren, og filtratet inddampes. Remanensen optages i 4-methyl-2-pentanon og en lille smule trichlormethan.To 0.5 parts of a solution of 2 parts of thiophene in 40 parts of ethanol are added 2 parts of cydopentanone, 5.5 parts of N- (4-piperidinyl) -2-pyrimidinamine and 120 parts of methanol. The whole is hydrogenated at normal pressure and at room temperature with 2 parts palladium-on-charcoal 10%. After the calculated amount of hydrogen is taken up, the catalyst is filtered off and the filtrate is evaporated. The residue is taken up in 4-methyl-2-pentanone and a small amount of trichloromethane.

Det hele udvaskes to gange med fortyndet natriumhydroxidopløs-ning, tørres, filtreres og inddampes. Remanensen udkrystalliseres 27 150478 fra 2,2'-oxybispropan. Produktet frafiltreres og tørres til dannelse af 2,3 dele N-(l-cyclopentyl-4-piperidinyl)-2-pyrimidin-amin, smeltepunkt 118 °C.The whole is washed twice with dilute sodium hydroxide solution, dried, filtered and evaporated. The residue is crystallized from 2,2'-oxybispropane. The product is filtered off and dried to give 2.3 parts of N- (1-cyclopentyl-4-piperidinyl) -2-pyrimidine-amine, m.p. 118 ° C.

Eksempel 21 -Example 21 -

Til 0,5 dele af en opløsning af 2 dele thiophen i 40 dele ethanol sættes 4 dele 2-propanon, 4,5 dele N-(4-piperidinyl)-2-pyrimidinamin og 120 dele methanol. Det hele hydrogeneres ved normalt tryk og ved stuetemperatur med 2 dele palladium-på-trækul katalysator 10%. Efter optagelse af den beregnede mængde hydrogen frafiltreres katalysatoren, og filtratet inddampes. Remanensen opløses i trichlormethan. Opløsningen udvaskes med en fortyndet natriumhydroxidopløsning og vand efter hinanden, tørres, filtreres og inddampes til dannelse af 3 dele N-[1—(1-methylethyl)-4-piperidinyl]-2-pyrimidinamin som remanens.To 0.5 parts of a solution of 2 parts of thiophene in 40 parts of ethanol are added 4 parts of 2-propanone, 4.5 parts of N- (4-piperidinyl) -2-pyrimidinamine and 120 parts of methanol. The whole is hydrogenated at normal pressure and at room temperature with 2 parts palladium-on-charcoal catalyst 10%. After taking up the calculated amount of hydrogen, the catalyst is filtered off and the filtrate is evaporated. The residue is dissolved in trichloromethane. The solution is washed with a dilute sodium hydroxide solution and water successively, dried, filtered and evaporated to give 3 parts of N- [1- (1-methylethyl) -4-piperidinyl] -2-pyrimidinamine as residue.

Eksempel 22Example 22

Til en omrørt og under opvarmning tilbagesvalet opslæmning af 2 dele lithiumaluminiumhydrid i 120 dele 1,1'-oxybisethan sættes dråbevis en opløsning af 13 dele ethyl-4-[N-(2,6-dimethyl-phenyl)amino]-1-piperidincarboxylat i 40 dele 1,11-oxybisethan. Efter endt tilsætning fortsættes omrøring og opvarmning under tilbagesvaling i 20 timer. Reaktionsblandingen afkøles til 5 °C, og 7 dele vand tilsættes. Det dannede bundfald frafiltreres, udvaskes på filteret med 1,1'-oxybisethan, og filtratet inddampes. Den olieagtige remanens destilleres til dannelse af 5,8 dele N-(2,6-dimethylphenyl)-l-methyl-4-piperidinamin, kogepunkt 90 -93 °c ved 0,003 mm tryk. Ved henstand størkner destillatet til dannelse af fast N-(2,6-dimethylphenyl)-l-methyl-4-piperidinamin med et smeltepunkt på 45 °C.To a stirred and refluxed slurry of 2 parts of lithium aluminum hydride in 120 parts of 1,1'-oxybisethane is added dropwise a solution of 13 parts of ethyl 4- [N- (2,6-dimethyl-phenyl) amino] -1-piperidinecarboxylate in 40 parts of 1,11-oxybisethane. After the addition is complete, stirring and heating under reflux are continued for 20 hours. The reaction mixture is cooled to 5 ° C and 7 parts of water are added. The resulting precipitate is filtered off, washed on the filter with 1,1'-oxybisethane and the filtrate is evaporated. The oily residue is distilled to give 5.8 parts of N- (2,6-dimethylphenyl) -1-methyl-4-piperidinamine, boiling point 90 -93 ° C at 0.003 mm pressure. Upon standing, the distillate solidifies to form solid N- (2,6-dimethylphenyl) -1-methyl-4-piperidinamine, m.p. 45 ° C.

Eksempel 23Example 23

En blanding af 50 dele 4-(phenylamino)-1-(phenylmethyl)-4-piperidincarboxamid og 600 dele koncentreret saltsyreopløsning holdes opvarmet under tilbagesvaling i 16 timer. Efter afkøling koncentreres reaktionsblandingen under formindsket tryk til et 150478 28 volumen på 400 dele, hvorefter et bundfald dannes. Dette frafiltreres, udvaskes med vand og 2-propanon og tørres til dannelse af 43 dele 4-(phenylamino)-1-(phenylmethyl)-4-piperidincarboxylsyre,dihydro-chlorid, smeltepunkt 261 - 263 °C (dek.).A mixture of 50 parts of 4- (phenylamino) -1- (phenylmethyl) -4-piperidinecarboxamide and 600 parts of concentrated hydrochloric acid solution is kept refluxed for 16 hours. After cooling, the reaction mixture is concentrated under reduced pressure to a volume of 400 parts and a precipitate is formed. This is filtered off, washed with water and 2-propanone and dried to give 43 parts of 4- (phenylamino) -1- (phenylmethyl) -4-piperidinecarboxylic acid, dihydrochloride, mp 261-263 ° C (dec).

En blanding af 19 dele 4-(phenylamino)-l-(phenylmethyl)-4-piperidincarboxylsyre,dihydrochlorid, 14,4 dele svovlsyre og 64 dele ethanol omrøres og holdes opvarmet under tilbagesvaling i 16 timer. Opløsningsmidlet fradekanteres. Remanensen opløses i vand. Den vandige opløsning gøres alkalisk med ammoniumhydroxid og ekstraheres med en blanding af methylbenzen og 2,2'-oxybispropan. De forenede organiske lag tørres over magnesiumsulfat, filtreres og inddampes. Den olieagtige remanens opløses i 200 dele 2,2'-oxybispropan, og gasformig hydrogenchlorid indføres i opløsningen. Det udfældede hydrochlorid frafiltreres, udvaskes med 2-propanol, frafiltreres igen og tørres til dannelse af 11,5 dele ethyl-4-(phenylamino)-1-(phenylmethyl)-4-piperidincarboxylat, dihydrochlorid, smeltepunkt 212 - 214,4 °C.A mixture of 19 parts of 4- (phenylamino) -1- (phenylmethyl) -4-piperidinecarboxylic acid, dihydrochloride, 14.4 parts of sulfuric acid and 64 parts of ethanol is stirred and kept under reflux for 16 hours. The solvent is decanted off. The residue is dissolved in water. The aqueous solution is made alkaline with ammonium hydroxide and extracted with a mixture of methylbenzene and 2,2'-oxybispropane. The combined organic layers are dried over magnesium sulfate, filtered and evaporated. The oily residue is dissolved in 200 parts of 2,2'-oxybispropane and gaseous hydrogen chloride is introduced into the solution. The precipitated hydrochloride is filtered off, washed with 2-propanol, filtered again and dried to give 11.5 parts of ethyl 4- (phenylamino) -1- (phenylmethyl) -4-piperidinecarboxylate, dihydrochloride, mp 212 - 214.4 ° C .

Til en omrørt og under opvarmning tilbagesvalet opløsning af 101,4 delé ethyl-4-(phenylamino)-1-(phenylmethyl)-4-piperidincarboxylat i 640 dele tør benzen sættes dråbevis en opløsning af 172 dele natrium-dihydro-bis(2-methoxyethoxy)aluminat, 70% i benzen, i 160 dele tør benzen. Efter endt tilsætning fortsættes omrøring i 2 timer og 30 minutter ved 80 °C. Reaktionsblandingen afkøles, hældes i isvand, gøres alkalisk med natriumhydroxidopløsning, og produktet ekstraheres med benzen. Ekstrakten udvaskes 2 gange med vand, tørres, filtreres og inddampes. Remanensen omdannes til hydrochloridsaltet i 2-propanol og 1,1'-oxy-bisethan. Saltet frafiltreres, koges i 2-propanol, og efter afkøling frafiltreres produktet. Det koges endnu engang i aceto-nitril, og saltet frafiltreres igen efter afkøling. Den frie base frigøres på konventionel måde. Efter ekstraktion med 1,1'-oxy-bisethan udvaskes basen med vand, tørres og inddampes til dannelse af 56,6 dele 4-(phenylamino)-1-(phenylmethyl)-4-piperidin-methanol som olieagtig remanens.To a stirred and refluxed solution of 101.4 parts of ethyl 4- (phenylamino) -1- (phenylmethyl) -4-piperidinecarboxylate in 640 parts of dry benzene is added dropwise a solution of 172 parts of sodium dihydro-bis (2- methoxyethoxy) aluminate, 70% in benzene, in 160 parts of dry benzene. After the addition is complete, stirring is continued for 2 hours and 30 minutes at 80 ° C. The reaction mixture is cooled, poured into ice water, made alkaline with sodium hydroxide solution and the product extracted with benzene. The extract is washed twice with water, dried, filtered and evaporated. The residue is converted to the hydrochloride salt in 2-propanol and 1,1'-oxy-bisethane. The salt is filtered off, boiled in 2-propanol and after cooling the product is filtered off. It is again boiled in acetonitrile, and the salt is filtered off again after cooling. The free base is released in a conventional manner. After extraction with 1,1'-oxy-bisethane, the base is washed with water, dried and evaporated to give 56.6 parts of 4- (phenylamino) -1- (phenylmethyl) -4-piperidine-methanol as oily residue.

Til en opløsning af 32 dele 4-(phenylamino)-1-(phenylmethyl) -4-piperidinmethanol i 90 dele benzen sættes 0,2 dele Ν,Ν,Ν-triethylbenzenmethanaminiumchlorid og 150 dele natriumhydroxidopløsning 60%. Efter kraftig omrøring tilsættes dråbevis 10,9 dele dimethylsulfat ved en temperatur under 30 °C.To a solution of 32 parts of 4- (phenylamino) -1- (phenylmethyl) -4-piperidine methanol in 90 parts of benzene is added 0.2 parts of Ν, Ν, Ν-triethylbenzene methanaminium chloride and 150 parts of sodium hydroxide solution 60%. After vigorous stirring, 10.9 parts of dimethyl sulfate are added dropwise at a temperature below 30 ° C.

29 15047829 150478

Efter endt tilsætning fortsættes omrøring ved stuetemperatur, først i 2 timer og 30 minutter og efter tilsætning af en anden portion af 2,6 dele dimethylsulfat i yderligere 1 time og 30 minutter. Reaktionsblandingen afkøles i isvand, og 200 dele vand tilsættes. Den organiske fase fraskilles, og den vandige fase ekstraheres med benzen. De forenede organiske faser udvaskes med vand, tørres, filtreres og inddampes. Remanensen renses ved søjle-chromatografi over silicagel under anvendelse af en blanding af trichlormethan og 3% methanol, som er mættet med ammoniak, som elueringsmiddel. De rene fraktioner samles, og elueringsmidlet afdampes til dannelse af 24,8 dele 4-(methoxymethyl)-N-phenyl-1-(phenylmethyl)-4-piperidinamin som remanens.After the addition is complete, stirring is continued at room temperature, first for 2 hours and 30 minutes and after the addition of another portion of 2.6 parts of dimethyl sulfate for an additional 1 hour and 30 minutes. The reaction mixture is cooled in ice water and 200 parts of water are added. The organic phase is separated and the aqueous phase is extracted with benzene. The combined organic phases are washed with water, dried, filtered and evaporated. The residue is purified by column chromatography over silica gel using a mixture of trichloromethane and 3% methanol saturated with ammonia as eluent. The pure fractions are collected and the eluent is evaporated to give 24.8 parts of 4- (methoxymethyl) -N-phenyl-1- (phenylmethyl) -4-piperidinamine as residue.

En blanding af 10 dele 4-(methoxymethyl)-N-pheny1-1-(phenylmethyl)-4-piperidinamin og 200 dele eddikesyre hydrogeneres ved normalt tryk og ved stuetemperatur med 2 dele palladium-på-trækul katalysator 10%. Efter at den beregnede mængde hydrogen er optaget, frafiltreres katalysatoren, og filtratet inddampes.A mixture of 10 parts of 4- (methoxymethyl) -N-phenyl-1- (phenylmethyl) -4-piperidinamine and 200 parts of acetic acid is hydrogenated at normal pressure and at room temperature with 2 parts of palladium-on-charcoal catalyst 10%. After the calculated amount of hydrogen is taken up, the catalyst is filtered off and the filtrate is evaporated.

Den olieagtige remanens opløses i vand, afkøles og gøres alkalisk med ammoniumhydroxid. Produktet ekstraheres med trichlormethan. Ekstrakten udvaskes med vand, tørres, filtreres og inddampes.The oily residue is dissolved in water, cooled and made alkaline with ammonium hydroxide. The product is extracted with trichloromethane. The extract is washed with water, dried, filtered and evaporated.

Den olieagtige remanens renses ved søjle-chromatografi over silicagel under anvendelse af en blanding af trichlormethan og methanol (90:10 efter volumen), mættet med gasformig ammoniak, som elueringsmiddel. De rene fraktioner samles, og elueringsmidlet afdampes til dannelse af 4,5 dele 4-(methoxymethyl)-N-pheny1-4-piperidinamin som en olieagtig remanens.The oily residue is purified by column chromatography over silica gel using a mixture of trichloromethane and methanol (90:10 by volume), saturated with gaseous ammonia, as eluent. The pure fractions are combined and the eluent is evaporated to give 4.5 parts of 4- (methoxymethyl) -N-phenyl-4-piperidinamine as an oily residue.

En blanding af 10 dele 2-brompropan, 9 dele 4-(methoxymethyl) -N-phenyl-4-piperidinamin, 4,9 dele N,N-diethylethan-amin og 72 dele Ν,Ν-dimethylacetamid omrøres og holdes opvarmet under tilbagesvaling i 10 timer og 25 minutter. Efter afkøling frafiltreres det dannede N,N-diethylethanamin,hydrobromid, og filtratet fortyndes med vand. Produktet ekstraheres med methyl-benzen. Ekstrakten udvaskes grundigt med vand, tørres, filtreres og inddampes. Remanensen renses ved søjle-chromatografi over silicagel under anvendelse af en blanding af trichlormethan og methanol (90:10) som elueringsmiddel. De rene fraktioner samles, og elueringsmidlet afdampes til dannelse af 5,7 dele (42,6%) 4-(methoxymethyl)-1-(1-methylethyl)-N-phenyl-4-piperidinamin som olieagtig remanens.A mixture of 10 parts of 2-bromopropane, 9 parts of 4- (methoxymethyl) -N-phenyl-4-piperidinamine, 4.9 parts of N, N-diethylethane-amine and 72 parts of Ν, Ν-dimethylacetamide is stirred and kept under reflux. for 10 hours and 25 minutes. After cooling, the resulting N, N-diethylethanamine, hydrobromide is filtered off and the filtrate is diluted with water. The product is extracted with methylbenzene. The extract is thoroughly washed with water, dried, filtered and evaporated. The residue is purified by column chromatography over silica gel using a mixture of trichloromethane and methanol (90:10) as eluent. The pure fractions are collected and the eluent is evaporated to give 5.7 parts (42.6%) of 4- (methoxymethyl) -1- (1-methylethyl) -N-phenyl-4-piperidinamine as oily residue.

30 1504783047478

Fremstilling af slutprodukter.Manufacture of end products.

Eksempel 2 4Example 2 4

En blanding af 20 dele ethyl-4-[N-(2-chlorphenyl)-N-(phenylacetyl)amino]-l-piperidincarboxylat og 300 dele hydrogen-bromidsyreopløsning 48% omrøres og holdes opvarmet under tilbagesvaling i 1 time og 10 minutter. Hydrogenbromidsyreopløsningen 48% fjernes i vakuum, og til remanensen sættes vand og natrium-hydroxidopløsning efter hinanden. Den frie base ekstraheres med trichlormethan. Ekstrakten tørres og inddampes. Den faste remanens udvaskes med l,l'-oxybisethan og tørres, til dannelse af 10,6 dele N-(2-chlorphenyl)-N-(4-piperidinyl)benzenacetamid, smeltepunkt 135,5 °C.A mixture of 20 parts of ethyl 4- [N- (2-chlorophenyl) -N- (phenylacetyl) amino] -1-piperidinecarboxylate and 300 parts of hydrobromic acid solution 48% is stirred and kept under reflux for 1 hour and 10 minutes. The hydrobromic acid solution 48% is removed in vacuo and to the residue are added water and sodium hydroxide solution successively. The free base is extracted with trichloromethane. The extract is dried and evaporated. The solid residue is washed with 1,1'-oxybisethane and dried to give 10.6 parts of N- (2-chlorophenyl) -N- (4-piperidinyl) benzeneacetamide, mp 135.5 ° C.

Eksempel 25Example 25

Efter fremgangsmåden i Eksempel 24 og under anvendelse af - en ækvivalent mængde af et passende ethyl-4-[N-aryl-N-(arylacetyl)-amino]-l-piperidincarboxylat i stedet for det deri anvendte ethyl-4-[N-(2-chlorphenyl)-N-(phenylacetyl)amino]-l-piperidincarboxylat opnås de følgende forbindelser: Ο'ϊ , '- N-C-CH^-Ar I 2Following the procedure of Example 24 and using an equivalent amount of an appropriate ethyl 4- [N-aryl-N- (arylacetyl) amino] -1-piperidinecarboxylate in place of the ethyl 4- [N- (2-Chlorophenyl) -N- (phenylacetyl) amino] -1-piperidinecarboxylate gives the following compounds: Ο'ϊ, '- NC-CH₂-Ar I 2

Ar 31 150478Ar 31 150478

Ar Ar"*- smeltepunktAr Ar + melting point

2- Cl,6-CH3-C6H3 CgH5 157 °C2- Cl, 6-CH3-C6H3 CgH5 157 ° C

4“F-C6H4 C6H5 96,5 °C4 ° F-C6H4 C6H5 96.5 ° C

3.4- (Ci)2”cgH3 C6H5 81 °C3.4- (Ci) 2 ”cgH3 C6H5 81 ° C

3- Cl-C6H4 CgH5 110,5 °C3- C1-C6H4 CgH5 110.5 ° C

4- Cl-C6H4 4-P-CgH4 109 °C4- C1-C6H4 4-P-CgH4 109 ° C

4-Cl-C,H. 3-CH,-C,H. 104,5 °C4-Cl-C, H. 3-CH, -C, H. 104.5 ° C

4-Br-CgH4 C6H53 121,5 °C4-Br-CgH4 C6H53 121.5 ° C

4-Cl-C6H4 2-Cl-C6H4 72,9 °C4-C1-C6H4 2-C1-C6H4 72.9 ° C

4-Cl-CgH4 3-Cl-CgH4 64 °C4-Cl-CgH4 3-Cl-CgH4 64 ° C

2-Cl,6-CH3-CgH3 4-Cl-CgH4 120,7 °C2-Cl, 6-CH3-CgH3 4-Cl-CgH4 120.7 ° C

4-Cl-CgH4 2,6-(CH3)2-CgH3 147,3 °C4-Cl-CgH4 2.6- (CH3) 2-CgH3 147.3 ° C

3.4- (Cl)2-CgH3 4-Cl-CgH4 98,7 °C3.4- (Cl) 2-CgH3 4-Cl-CgH4 98.7 ° C

2.5- (Cl)2-CgH3 4-Cl-CgH4 125,6 °C2.5- (Cl) 2-CgH3 4-Cl-CgH4 125.6 ° C

2.6- (Cl)2-CgH3 4-Cl-CgH4 126,3 °C2.6- (Cl) 2-CgH3 4-Cl-CgH4 126.3 ° C

Eksempel 26Example 26

En blanding af 5 dele ethyl-4-[N-(2,6-dimethylphenyl)-N-(phenylacetyl)amino]-1-piperidincarboxylat i 60 dele hydrogen-bromidsyreopløsning 48% opvarmes indtil udviklingen af carbondioxid ophører. Opvarmning fortsættes i 15 minutter ved en temperatur mellem 80 og 120 °C. Reaktionsblandingen inddampes. Den faste remanens udvaskes med methylbenzen og 2-propanon efter hinanden og tørres til dannelse af 4,1 dele N-(2,6-dimethylphenyl)-N-(4-piperidinyl)benzenacetamid, hydrobromid, smeltepunkt 251,5 °C.A mixture of 5 parts of ethyl 4- [N- (2,6-dimethylphenyl) -N- (phenylacetyl) amino] -1-piperidinecarboxylate in 60 parts of hydrogen bromic acid solution is heated 48% until the evolution of carbon dioxide ceases. Heating is continued for 15 minutes at a temperature between 80 and 120 ° C. The reaction mixture is evaporated. The solid residue is washed with methylbenzene and 2-propanone one after the other and dried to give 4.1 parts of N- (2,6-dimethylphenyl) -N- (4-piperidinyl) benzeneacetamide, hydrobromide, mp 251.5 ° C.

Eksempel 2 7Example 2 7

En blanding af 10 dele ethyl-4-[N-(4-chlorphenyl)-N-(phenyl-acetyl)amino]-1-piperidincarboxylat og 125 dele iseddikesyre, som forud er mættet med gasformig hydrogenbromid, opvarmes under omrøring i 9 timer og 45 minutter ved 62 °C. Reaktionsblandingen afkøles og iseddikesyren afdampes i vakuum. Den halvfaste remanens optages i 150 dele vand, hvorpå der gøres alkalisk med en koncentreret natriumhydroxidopløsning, og produktet ekstraheres med tri-chlormethan. Ekstrakten tørres over natriumsulfat og inddampes.A mixture of 10 parts of ethyl 4- [N- (4-chlorophenyl) -N- (phenylacetyl) amino] -1-piperidinecarboxylate and 125 parts of glacial acetic acid, previously saturated with gaseous hydrogen bromide, is heated under stirring for 9 hours. and 45 minutes at 62 ° C. The reaction mixture is cooled and the glacial acetic acid is evaporated in vacuo. The semi-solid residue is taken up in 150 parts of water, then made alkaline with a concentrated sodium hydroxide solution and the product is extracted with trichloromethane. The extract is dried over sodium sulfate and evaporated.

Den olieagtige remanens tritureres i 56 dele l,l'-oxybisethan, og den faste rå frie base frafiltreres. Denne omdannes til hydro-The oily residue is triturated in 56 parts of 1,1'-oxybisethane and the solid crude free base is filtered off. This is converted into hydro

AA

32 150478 chloridsaltet på sædvanlig måde i 1,1'-oxybisethan og 2-propanon til dannelse af 4 dele N-(4-chlorphenyl)-N-(4-piperidinyl)benzen-acetamid,hydrochlorid, smeltepunkt 206,5 °C.The chloride salt in the usual manner in 1,1'-oxybisethane and 2-propanone to give 4 parts of N- (4-chlorophenyl) -N- (4-piperidinyl) benzene-acetamide, hydrochloride, m.p. 206.5 ° C.

Eksempel 2 8Example 2 8

Efter fremgangsmåden i Eksempel 2 7 og under anvendelse af en ækvivalent mængde af et passende ethyl-4-[N-aryl-N-(arylacetyl)-amino]-1-piperidincarboxylat som udgangsmateriale fremstilles de følgende forbindelser: N-(2,6-dimethylphenyl)-N-(4-piperidinyl)-2-thiophenacetamid, smeltepunkt 128 °C; N-(4-chlorphenyl)-N-(4-piperidinyl)-2-thiophenacetamid, hydrochlorid, smeltepunkt 201,5 °C* 4-chlor-N-(4-chlorphenyl)-N-(4-piperidinyl)-4-benzen-acetamid,hydrochlorid, smeltepunkt 222 °C og N-(4-chlorphenyl)-4-methyl-N(4-piperidinylJbenzenacetamid; smeit<·: jnkt 121 °C.Following the procedure of Example 27 and using an equivalent amount of an appropriate ethyl 4- [N-aryl-N- (arylacetyl) amino] -1-piperidinecarboxylate as starting material, the following compounds are prepared: N- (2.6 -dimethylphenyl) -N- (4-piperidinyl) -2-thiophenacetamide, mp 128 ° C; N- (4-chlorophenyl) -N- (4-piperidinyl) -2-thiophenacetamide, hydrochloride, m.p. 201.5 ° C * 4-chloro-N- (4-chlorophenyl) -N- (4-piperidinyl) -4 -benzene-acetamide, hydrochloride, m.p. 222 ° C and N- (4-chlorophenyl) -4-methyl-N (4-piperidinyl) benzeneacetamide;

Eksempel 2 9Example 2 9

Til en varm (40 °C) opløsning af 12 dele kaliumhydroxid i 240 dele 2-propanol sættes på én gang 21 dele ethyl-4-^N-(4-chlorphenyl)-N-[(4-methoxypheny1)acetyl]amino^ -1-piperidincarboxy lat, og det hele omrøres og holdes opvarmet under tilbaqe- svaling i 21 timer. Reaktionsblandingen afkøles, filtreres, og filtratet inddampes. Remanensen optages i vand, og den vandige opløsning gøres sur med fortyndet saltsyreopløsning. Syreopløsningen udvaskes med 1,1'-oxybisethan, gøres alkalisk med natriumhydroxid, og den frie base ekstraheres med methylbenzen. Ekstrakten tørres, filtreres og inddampes. Remanensen opløses i 1,1'-oxybisethan, og efter udkrystallisation opnås 10 dele N-(4-chlorphenyl) -4-methoxy-N- {4-piperidinyl) be. .er.acetamid, smeltepunkt 129,5 °C.To a hot (40 ° C) solution of 12 parts of potassium hydroxide in 240 parts of 2-propanol is added at once 21 parts of ethyl 4- [N- (4-chlorophenyl) -N - [(4-methoxyphenyl) acetyl] amino] -1-piperidinecarboxy lat, and the whole is stirred and kept under reflux for 21 hours. The reaction mixture is cooled, filtered and the filtrate is evaporated. The residue is taken up in water and the aqueous solution acidified with dilute hydrochloric acid solution. The acid solution is washed out with 1,1'-oxybisethane, made alkaline with sodium hydroxide and the free base extracted with methylbenzene. The extract is dried, filtered and evaporated. The residue is dissolved in 1,1'-oxybisethane and after crystallization 10 parts of N- (4-chlorophenyl) -4-methoxy-N- (4-piperidinyl) bee are obtained. acetamide, m.p. 129.5 ° C.

Eksempel 30Example 30

Til en omrørt og varm (40 °C) opløsning af 12 dele kaliumhydroxid i 200 dele 2-propanol sættes på én gang 21 dele ethyl-4- ^N- (4-chlorphenyl) -N- [ (3-methoxyphenyl) acetyl] amino j· -1-piperidincarboxylat, og det hele omrøres og holdes opvarmet under tilbagesvaling i 17 timer. Reaktionsblandingen afkøles, filtreres 33 150478 og inddampes. Den halvfaste remanens gøres sur med en fortyndet saltsyreopløsning, udvaskes med l,l'-oxybisethan, og den vandige syrefase gøres alkalisk med natriumhydroxidopløsning. Den frie base ekstraheres med trichlormethan. Ekstrakten tørres og inddampes. Remanensen udkrystalliseres fra en blanding af 1,1'-oxybisethan og hexan til opnåelse af 7,8 dele N-(4-chlorphenyl)- 3-methoxy-N-(4-piperidinyl)benzenacetamid, smeltepunkt 85,7 °C.To a stirred and hot (40 ° C) solution of 12 parts of potassium hydroxide in 200 parts of 2-propanol is added at once 21 parts of ethyl 4- [N- (4-chlorophenyl) -N- [(3-methoxyphenyl) acetyl] amino β-1-piperidinecarboxylate, and it is all stirred and kept under reflux for 17 hours. The reaction mixture is cooled, filtered and evaporated. The semi-solid residue is acidified with a dilute hydrochloric acid solution, washed with 1,1'-oxybisethane and the aqueous acid phase made alkaline with sodium hydroxide solution. The free base is extracted with trichloromethane. The extract is dried and evaporated. The residue is crystallized from a mixture of 1,1'-oxybisethane and hexane to give 7.8 parts of N- (4-chlorophenyl) -3-methoxy-N- (4-piperidinyl) benzeneacetamide, mp 85.7 ° C.

Eksempel 31Example 31

Til en omrørt opslæmning af 5 dele N-(4-chlorphenyl)-N-(4-piperidinyl)benzenacetamid, 5 dele natriumcarbonat, nogle få krystaller kaliumiodid i 200 dele butanol sættes dråbevis 4 dele 2-brompropan ved stuetemperatur. Efter endt tilsætning omrøres det hele og holdes opvarmet under tilbagesvaling i 20 timer. Derpå tilsættes en anden portion af 4 dele 2-brompropan, og omrøring og opvarmning under tilbagesvaling fortsættes i yderligere 19 timer. Reaktionsblandingen afkøles, filtreres og filtratet inddampes. Fra den olieagtige frie base fremstilles hydro-chloridsaltet på sædvanlig måde i 1,11-oxybisethan og 2-propanoh.To a stirred slurry of 5 parts of N- (4-chlorophenyl) -N- (4-piperidinyl) benzeneacetamide, 5 parts of sodium carbonate, a few crystals of potassium iodide in 200 parts of butanol, 4 parts of 2-bromopropane are added dropwise at room temperature. After the addition is complete, it is all stirred and kept under reflux for 20 hours. Then another portion of 4 parts of 2-bromopropane is added and stirring and heating under reflux for a further 19 hours. The reaction mixture is cooled, filtered and the filtrate is evaporated. From the oily free base, the hydrochloride salt is prepared in the usual manner in 1,11-oxybisethane and 2-propanoh.

Det udfældede faste salt frafiltreres og udkrystalliseres fra en blanding af 2-propanon og 2-propanol til dannelse af 2 dele N-(4-chlorphenyl)-N-[1-(1-methylethyl)-4-piperidinyl]benzenacetamid, hydrochlorid, smeltepunkt 263 °C.The precipitated solid salt is filtered off and crystallized from a mixture of 2-propanone and 2-propanol to form 2 parts of N- (4-chlorophenyl) -N- [1- (1-methylethyl) -4-piperidinyl] benzeneacetamide, hydrochloride, mp 263 ° C.

Eksempel 32Example 32

Efter fremgangsmåden i Eksempel 31 og under anvendelse af ækvivalente mængder af henholdsvis et passende bromid og et passende N-ary1-N-(4-piperidinyl)arylacetamid som udgangsmaterialer fremstilles de følgende forbindelser i hydrochloridsalt-form: 34 150473 . — j . υ υ υ υυυυυ υ jFollowing the procedure of Example 31 and using equivalent amounts of a suitable bromide and a suitable N-aryl-N- (4-piperidinyl) arylacetamide, respectively, as starting materials, the following compounds are prepared in hydrochloride salt form: 34 150473. - j. υ υ υ υυυυυ υ j

Π. ο Ο Ο βββΦΟ Ο JΠ. ο Ο Ο βββΦΟ Ο J

g LnOmUinUininininvoU m Jg LnOmUinUininininfoU m J

Μ κ Ο Ο #* Ο Ο Γ '* Κ Ο Ο # * Ο Ο Γ '

w CONOO'vO^N^OhCO^ ΙΛ Iw CONOO'vO ^ N ^ OhCO ^ ΙΛ I

Γ— O^CO h vO vO νΟ C*vJ r-vO^OCM ’’Φ JΓ— O ^ CO h vO vO νΟ C * vJ r-vO ^ OCM '' Φ J

νννννννννννν CM Jνννννννννννν CM J

-- I- I

ο ί g uf1 ίο ί g uf1 ί

Μ , II, I

Ο Η Η Η Η Η Η Η Η Η pH Η Η Η IΗ Η Η Η Η Η Η Η Η pH Η Η Η I

«η ουυυυυυυυυυυ υ « £ ffiWffiKKffiwwffiWKffi a j (ΰ ι σι ι ι __;_ι ί . _ *φ a ^ ι«Η ουυυυυυυυυυυ υ« £ ffiWffiKKffiwwffiWKffi a j (ΰ ι σι ι ι __; _ ι ί. _ * Φ a ^ ι

U ffi Ό X _μ IU fi Ό X _µ I

<£ . νθ Ο ^ o tji J<£. νθ Ο ^ o tji J

* * Ο » Ο Κνθ ! ίτΓ* ^ g g '« Β O '«V ί η u ·ΐ J"·? Κ ' S -i J"»!'1 ι* * Ο »Ο Κνθ! ίτΓ * ^ g g '«Β O'« V ί η u · ΐ J "·? Κ 'S -i J" »!' 1 ι

Ό, < £ B -g U Bn W- ® h O U tt! w JΌ, <£ B -g U Bn W- ® h O U tt! w J

^ μ (VjOcd^U^UU^OOT^UU J^ µ {VjOcd ^ U ^ UU ^ OOT ^ UU J

8 Z-« ;8 Z- «;

LJ a" a" £ „ - ILJ a "a" £ „- I

X o° o° <? *, ►J - · . * co η Ο ι u * J? J? ^ ffi * ι J* J? 3 K 'Ίο^οΕ g ffi nK K K nK s ! ^ Oil! E ό I OCT ό ό Έ" ^ ό 1X o ° o ° <? *, ►J - ·. * co η Ο ι u * J? J? ^ ffi * ι J * J? 3 K 'Ίο ^ οΕ g fi nK K K nK s! ^ Oil! E ό I OCT ό ό Έ "^ ό 1

UnoUvoUoOUOoOU JUnoUvoUoOUOoOU J

I c-c. ι 1 Cl. ι ι I — I I JIn c-c. ι 1 Cl. ι ι I - I I J

Η I I H i-^ r—I t Η Η Η I ι—I r-4 IΗ I I H i- ^ r — I t Η Η Η I ι — I r-4 I

UvDnoUUO'HOUU^OU i 1..111.111.11 !UvDnoUUO'HOUU ^ OU i 1..111.111.11!

______I______IN

Λ ί CO · a υ ! w * a ;CO ί CO · a υ! w * a;

I I I I I I I I I I I U II I I I I I I I I I I U I

eeeeeeeeeee i ; υυυυυυυυυυυ ,eeeeeeeeeee i; υυυυυυυυυυυ,

I I I I I I I I I I I ON K II I I I I I I I I I I ON K I

j oo oo ^_ro ^_£J K Ο ιj oo oo ^ _ro ^ _ £ J K Ο ι

'"co ""£) cococococococococo^·· J'"co" "£) cocococococococococo ^ ·· J

EEEEEEEEEEEU*0 —! 1" ..... ............. - ι 35 150478 υ υ υ υ • ο ο ο ο £ in m m ιη g #* r «ν ·»EEEEEEEEEEEU * 0 -! 1 "..... ............. - ι 35 150478 υ υ υ υ • ο ο ο ο £ in m m ιη g # * r« ν · "

S if| h Γ* COS if | h Γ * CO

ro r- tn toro r- tn two

(Nj »—I Η H(Nj »—I Η H

SS

Μ Η Η H fHF Η Η H fH

o υ o υ o M M M ,μ π w h wo υ o υ o M M M, µ π w h w

rHrh

id w . in in m m n X ffi S3 ffiid w. in a m m n X fi S3 fi

^4 \0 vO sO O^ 4 \ 0 vO sO O

^ υ υ υ υ^ υ υ υ υ

χ κ χ Xκ κ χ X

\0 \D vO nO\ 0 \ D vO nO

»i υ υ υ υ»I υ υ υ υ

<£1111 r—( f—4 »—I *-H<£ 1111 r— (f — 4 »—I * -H

υ υ υ υυ υ υ υ

I I I II I I I

Ί* ^ -φ -ψΊ * ^ -φ -ψ

Vj ffi υVj fi υ

(SJ(SJ

κ ο i '~cn ffi X S , , ι_κ ο i '~ cn fi X S,, ι_

m in n O --1 <-i JiJm in n O --1 <-i JiJ

' £ X o « vo r- Hi £ υ υ υ u c α c 36 150478'£ X o «vo r- Hi £ υ υ υ u c α c 36 150478

Eksempel 33Example 33

Til en omrørt og varm (40°C) blanding af 4,75 dele (N- (4-fluorpheny1)-N-(4-piperidyl)benzenacetamid, 5 dele natriumcarbonat, nogle få krystaller kaliumiodid og 200 dele n-butanol sættes 3,1 dele 2-brompropan, og det hele omrøres og holdes opvarmet under tilbagesvaling i 24 timer. Dernæst tilsættes en anden portion af 4,1 dele 2-brom-propan, og omrøringen fortsætter ved tilbagesvalingstempe-ratur i yderligere 30 timer. Reaktionsblandingen afkøles, filtreres, og filtratet inddampes. Den olieagtige remanens størkner ved triturering i l,l*-oxybisethan. Det faste produkt frafiltreres og udkrystalliseres fra l,l*-oxybis-ethan til dannelse af 1,5 dele N-(4-fluorphenyl)-N-(2-pro-pyl-4-piperidyl)benzenacetamid, smp. 108,5°C.To a stirred and hot (40 ° C) mixture of 4.75 parts of (N- (4-fluorophenyl) -N- (4-piperidyl) benzeneacetamide, 5 parts of sodium carbonate, a few crystals of potassium iodide and 200 parts of n-butanol are added. , 1 part 2-bromopropane, and the whole is stirred and kept under reflux for 24 hours, then another portion of 4.1 parts of 2-bromopropane is added and stirring is continued at reflux temperature for an additional 30 hours. , the filtrate is evaporated. The oily residue solidifies by trituration of 11,11-oxybisethane. The solid product is filtered off and crystallized from 1,1,1-oxybisethane to give 1.5 parts of N- (4-fluorophenyl) - N- (2-propyl-4-piperidyl) benzeneacetamide, mp 108.5 ° C.

Eksempel 34Example 34

Efter fremgangsmåden i Eksempel 33 og under anvendelse af ækvivalente mængder af henholdsvis et passende bromid og et passende N-aryl-N-(4-piperidinyl)arylacetamid som udgangsmaterialer opnås de følgende forbindelser: *Q<i I ^Following the procedure of Example 33 and using equivalent amounts of a suitable bromide and a suitable N-aryl-N- (4-piperidinyl) arylacetamide, respectively, as starting materials, the following compounds are obtained:

Ar L Ar Ar1 smeltepunktAr L Ar Ar1 melting point

(CH3)2-CH- 4-Cl-C6H4 4-Cl-CgH4 106,5 °C(CH3) 2-CH-4-Cl-C6H4 4-Cl-CgH4 106.5 ° C

> 37 150478 L Ar Ar1 snip.> 37 150478 L Ar Ar1 snip.

(CH3)2-CH- 4-Br-C6H4 97eC(CH3) 2-CH-4-Br-C6H4 97 ° C

(CH3)2-CH- 4-Cl-C6H4 2-Cl-C6H4 143,2eC(CH3) 2-CH-4-C1-C6H4 2-C1-C6H4 143.2eC

(CH3)2-CH- 4-Cl-C6H4 3-OCH3-C6H4 96,4eC(CH3) 2-CH-4-C1-C6H4 3-OCH3-C6H4 96.4eC

(CH3)2-CH- 4-Cl-C6H4 3-Cl-C6H4 6l,6°C(CH3) 2-CH-4-C1-C6H4 3-C1-C6H4 6l, 6 ° C

(CH3)2-CH- 2-Cl,é-CH3-C6H3 4-Cl-C6H4 94,2eC(CH3) 2-CH-2-Cl, e-CH3-C6H3 4-Cl-C6H4 94.2eC

(CH3)2-CH- 4-Cl-C6H4 2,6-(CH3)2-C6H3 126,6eC(CH3) 2-CH-4-Cl-C6H4 2.6- (CH3) 2-C6H3 126.6 ° C

(CH3)2-CH- 2,5-(Cl)2-C6H3 4-Cl-C6H4 102,5°C(CH3) 2-CH-2,5- (Cl) 2-C6H3 4-Cl-C6H4 102.5 ° C

(CH3)2-CH- 2,6-(Cl)2-C6H3 4-Cl-C6H4 129, leC(CH3) 2-CH- 2.6- (Cl) 2-C6H3 4-Cl-C6H4 129, leC

(CH3)2-CH- 2-Cl-C6H4 C6Hg 87,5°C(CH3) 2-CH-2-Cl-C6H4 C6Hg 87.5 ° C

Eksempel 35 tExample 35 h

Til en omrørt og under opvarmning tilbagesvalet blanding af 5 dele N-(4-chlorphenyl)-N-(4-piperidinyl)benzenacetamid, 5 dele natriumhydrogencarbonat og 200 dele benzen sættes portionsvis 6/7 dele (brommethyl)cyclopropan, og omrøring og opvarmning under tilbagesvaling fortsættes i 23 timer. Reaktionsblandingen afkøles og filtreres. Filtratet inddampes. Den halvfaste remanens opløses i en blanding af benzen og 1,1'-oxybisethan. De udfældede urenheder frafiltreres, og filtratet inddampes igen. Fra den olieagtige fri base fremstilles hydrochloridsaltet på sædvanlig måde til dannelse» efter udkrystallisation af det rå salt fra en blanding af trichlormethan og 1,1'-oxybisethan» af 1,5 dele N-(4-chlorphenyl)-N-[1-(cyclopropylmethyl)-4-piperidinyl]benzen-acetamid,hydrochlorid, smeltepunkt 224 °C.To a stirred and refluxed mixture of 5 parts of N- (4-chlorophenyl) -N- (4-piperidinyl) benzeneacetamide, 5 parts of sodium bicarbonate and 200 parts of benzene are added portionwise 6/7 parts (bromomethyl) cyclopropane, and stirring and heating. refluxing is continued for 23 hours. The reaction mixture is cooled and filtered. The filtrate is evaporated. The semi-solid residue is dissolved in a mixture of benzene and 1,1'-oxybisethane. The precipitated impurities are filtered off and the filtrate is evaporated again. From the oily free base, the hydrochloride salt is prepared in the usual manner to form "after crystallization of the crude salt from a mixture of trichloromethane and 1,1'-oxybisethane" of 1.5 parts of N- (4-chlorophenyl) -N- [1- (cyclopropylmethyl) -4-piperidinyl] benzeneacetamide, hydrochloride, mp 224 ° C.

Eksempel 36Example 36

Til en omrørt opløsning af 5 dele N-(4-chlorphenyl)-N-(4-piperidinyl)benzenacetamid, 3,8 dele Ν,Ν-diethylethanamin i 200 dele benzen sættes portionsvis 5 dele 3-brom-1-propen. Efter 38 150478 endt tilsætning opvarmes det hele i 21 timer ved en temperatur imellem 50 - 60 °C. Reaktionsblandingen afkøles og filtreres. Filtratet udvaskes med vand, natriumhydrogencarbonatopløsning og vand efter hinanden, tørres over kaliumcarbonat og inddampes. Den olieagtige remanens omdannes til hydrochloridsaltet i 1,1'-oxybisethan og 2-propanon til dannelse af 4 dele N-(4-chlor-phenyl)-N-[1-(2-propenyl)-4-piperidinyl]benzenacetamid,hydro-chlorid, smeltepunkt 225,5 °C.To a stirred solution of 5 parts of N- (4-chlorophenyl) -N- (4-piperidinyl) benzeneacetamide, 3.8 parts of Ν, Ν-diethylethanamine in 200 parts of benzene is added portionwise 5 parts of 3-bromo-1-propene. After the addition is complete, the whole is heated for 21 hours at a temperature between 50 - 60 ° C. The reaction mixture is cooled and filtered. The filtrate is washed with water, sodium bicarbonate solution and water one after the other, dried over potassium carbonate and evaporated. The oily residue is converted to the hydrochloride salt in 1,1'-oxybisethane and 2-propanone to give 4 parts of N- (4-chlorophenyl) -N- [1- (2-propenyl) -4-piperidinyl] benzeneacetamide, hydro chloride, mp 225.5 ° C.

Eksempel 37 > Efter fremgangsmåden i Eksempel 36 og under anvendelse af en ækvivalent mængde af et passende N-aryl-N-(4-piperidinyl)-arylacetamid i stedet for det deri anvendte N-(4-chlorphenyl)-N-(4-piperidinyl)benzenacetamid fremstilles de følgende forbindelser: N-(2,6-dimethylphenyl)-N-[1-(2-propenyl)-4-piperidinyl]-2-thiophenacetamid,hydrochlorid, smeltepunkt 203,5 °C og N-(2,6-dimethylphenyl)-N-[1-(2-propenyl)-4-piperidinyl]-benzenacetamid,hydrochlorid, smeltepunkt 214 °C.Example 37> Following the procedure of Example 36 and using an equivalent amount of a suitable N-aryl-N- (4-piperidinyl) -arylacetamide in place of the N- (4-chlorophenyl) -N- (4- piperidinyl) benzeneacetamide, the following compounds are prepared: N- (2,6-dimethylphenyl) -N- [1- (2-propenyl) -4-piperidinyl] -2-thiophenacetamide, hydrochloride, mp 203.5 ° C and N- ( 2,6-dimethylphenyl) -N- [1- (2-propenyl) -4-piperidinyl] benzeneacetamide, hydrochloride, mp 214 ° C.

Eksempel 38Example 38

Til en varm opslæmning af 5 dele N-(4-chlorphenyl)-N-(4-piperidinyl)benzenacetamid, 5 dele natriumcarbonat, nogle få krystaller kaliumiodid i 200 dele n-butanol sættes 4 dele 2-chlor-2-methylpropan ved en temperatur på 30 - 40°C. Det hele omrøres og holdes opvarmet under tilbagesvaling i 140 timer hvorunder tilsættes 35 dele 2-chlor-2-methylpropan i portioner som følger: Efter en tilbagesvalingstid på 15 timer tilsættes 4 dele 2-chlor-2-methylpropan, efter 8 timer 10 dele, efter 16 timer 11 dele og endelig efter 47 timer 10 dele. Reaktionsblandingen afkøles, filtreres, og filtratet inddampes. Den halvfaste remanens opløses i en blanding af methylbenzen, dimethoxy-ethan og 1,1'-oxybisethan. Opløsningen filtreres fra- nogle urenheder, og filtratet inddampes igen. Fra den olieagtige 39 150478 remanens fremstilles hydrochloridsaltet i 1,11-oxybisethan på sædvanlig måde til dannelse, efter omkrystallisation af det rå faste salt fra 2-propanon, af 0,9 dele N-(4-chlorphenyl)-N-[1- (1,1-dimethylethyl)-4-piperidinyl]benzenacetamid,hydrochlorid, smeltepunkt 221 °C.To a hot slurry of 5 parts of N- (4-chlorophenyl) -N- (4-piperidinyl) benzeneacetamide, 5 parts of sodium carbonate, a few crystals of potassium iodide in 200 parts of n-butanol, 4 parts of 2-chloro-2-methylpropane are added temperature of 30 - 40 ° C. It is all stirred and kept under reflux for 140 hours, adding 35 parts of 2-chloro-2-methylpropane in portions as follows: After a reflux time of 15 hours, 4 parts of 2-chloro-2-methylpropane are added, after 8 hours, 10 parts, after 16 hours 11 parts and finally after 47 hours 10 parts. The reaction mixture is cooled, filtered and the filtrate is evaporated. The semi-solid residue is dissolved in a mixture of methylbenzene, dimethoxyethane and 1,1'-oxybisethane. The solution is filtered off from some impurities and the filtrate is evaporated again. From the oily residue, the hydrochloride salt in 1,11-oxybisethane is prepared in the usual manner to form, after recrystallization of the crude solid salt from 2-propanone, 0.9 parts of N- (4-chlorophenyl) -N- [1- (1,1-dimethylethyl) -4-piperidinyl] benzeneacetamide, hydrochloride, m.p. 221 ° C.

Eksempel 39Example 39

En blanding af 4 dele iodethan, 5 dele N-(2,6-dimethyl-phenyl)-N-(4-piperidinyl)benzenacetamid, 5 dele natriumcarbonat, nogle få krystaller kaliumiodid i 200 dele benzen omrøres og holdes opvarmet under tilbagesvaling i 23 timer. Reaktionsblandingen filtreres varm og filtratet inddampes i vakuum. Den faste remanens udkrystalliseres fra l,l'-oxybisethan til dannelse af 2 dele N-(2,6-dimethylphenyl)-N-(l-ethyl-4-piperidinyl)benzen-acetamid, smeltepunkt 86,4°C.A mixture of 4 parts of iodoethane, 5 parts of N- (2,6-dimethyl-phenyl) -N- (4-piperidinyl) benzeneacetamide, 5 parts of sodium carbonate, a few crystals of potassium iodide in 200 parts of benzene is stirred and kept under reflux for 23 hours. hours. The reaction mixture is filtered hot and the filtrate is evaporated in vacuo. The solid residue is crystallized from 1,1'-oxybisethane to give 2 parts of N- (2,6-dimethylphenyl) -N- (1-ethyl-4-piperidinyl) benzene acetamide, m.p. 86.4 ° C.

Eksempel 40Example 40

Efter fremgangsmåden i Eksempel 39 og under anvendelse af en ækvivalent mængde af et passende N-aryl-N-(4-piperidinyl)-arylacetamid i stedet for det deri anvendte N-(2,6-dimethylphenyl ) -N- (4-piperidinyl )benzenacetamid fremstilles de følgende forbindelser: 2-chlor-N-(4-chlorphenyl)-N-(l-ethyl-4-piperidinyl)-benzenacetamid,hydrochlorid, smeltepunkt 234,6 °Cj N-(4-chlorphenyl)-N-(l-ethyl-4-piperidinyl)-3-methyl-benzenacetamid, smeltepunkt 78,5 °C; N-(4-chlorphenyl)-N-(l-ethyl-4-piperidinyl)-4-methyl-benzenacetamid, smeltepunkt 50 °C og N-(4-chlorphenyl)-N-(l-ethyl-4-piperidinyl)-4-fluor-benzenacetamid, smeltepunkt 62,3 °C.Following the procedure of Example 39 and using an equivalent amount of an appropriate N-aryl-N- (4-piperidinyl) -arylacetamide in place of the N- (2,6-dimethylphenyl) -N- (4-piperidinyl) used therein ) benzeneacetamide, the following compounds are prepared: 2-chloro-N- (4-chlorophenyl) -N- (1-ethyl-4-piperidinyl) -benzeneacetamide, hydrochloride, mp 234.6 ° C N- (4-chlorophenyl) -N - (1-ethyl-4-piperidinyl) -3-methyl-benzeneacetamide, m.p. 78.5 ° C; N- (4-chlorophenyl) -N- (1-ethyl-4-piperidinyl) -4-methyl-benzeneacetamide, m.p. 50 ° C and N- (4-chlorophenyl) -N- (1-ethyl-4-piperidinyl) -4-fluoro-benzeneacetamide, m.p. 62.3 ° C.

Eksempel 4 1Example 4 1

Til en omrørt og under opvarmning tilbagesvalet blanding af 5 dele 4-chlor-N-(4-chlorphenyl)-N-(4-piperidinyl)benzen-acetamid, 5 dele natriumcarbonat, 0,4 dele kaliumiodid og 200 dele butanol sættes 4,7 dele 1-iodpropan, og det hele omrøres og tilbagesvales i 22 timer. Derpå tilsættes en anden portion 40 150478 af 4,b dele 1-iodpropan, og omrøring og opvarmning under tilbagesvaling fortsættes i 27 timer og 30 minutter. Reaktionsblandingen afkøles, filtreres, og filtratet inddampes. Den halvfaste remanens opløses i methylbenzen. Opløsningen filtreres fra nogle urenheder, og filtratet inddampes igen. Remanensen udkrystalliseres fra 1,1'-oxybisethan ved -10 °C til dannelse af 0,9 dele 4-chlor-N-(4-chlorphenyl)-N-(l-propyl-4-piperidinyl)benzenacetamid, smeltepunkt 118,6 °C.To a stirred and refluxed mixture of 5 parts of 4-chloro-N- (4-chlorophenyl) -N- (4-piperidinyl) benzene acetamide, 5 parts of sodium carbonate, 0.4 parts of potassium iodide and 200 parts of butanol is added 4, 7 parts of 1-iodopropane and it is all stirred and refluxed for 22 hours. Then a second portion of 4, b parts of 1-iodopropane is added and stirring and heating at reflux is continued for 27 hours and 30 minutes. The reaction mixture is cooled, filtered and the filtrate is evaporated. The semi-solid residue is dissolved in methylbenzene. The solution is filtered from some impurities and the filtrate is evaporated again. The residue is crystallized from 1,1'-oxybisethane at -10 ° C to give 0.9 parts of 4-chloro-N- (4-chlorophenyl) -N- (1-propyl-4-piperidinyl) benzeneacetamide, m.p. 118.6 ° C.

Eksempel 42Example 42

Til en omrørt opløsning af 4 dele N-(4-chlorphenyl)-N-(4-piperidinyl)benzenacetamid og 3 dele Ν,Ν-diethylethanamin i 200 dele benzen sættes portionsvis 4 dele 1-iodpropan, og det hele omrøres og opvarmes under tilbagesvaling i 47 timer. Derpå tilsættes en anden portion af 4 dele 1-iodpropan, og omrøring og opvarmning under tilbagesvaling fortsættes i yderligere 20 timer og 20 minutter. Reaktionsblandingen afkøles og filtreres. Filtratet udvaskes med vand, tørres og inddampes i vakuum. Fra den olieagtige fri base fremstilles hydrochloridsaltet i 1,1'-oxybisethan på sædvanlig måde. Det udfældede faste salt fra-filtreres og tørres til dannelse af 3,5 dele N-(4-chlorphenyl)-N-(l-propyl-4-piperidinyl)benzenacetamid,hydrochlorid, smeltepunkt 233,5 °C.To a stirred solution of 4 parts of N- (4-chlorophenyl) -N- (4-piperidinyl) benzeneacetamide and 3 parts of Ν, Ν-diethylethanamine in 200 parts of benzene is added portionwise 4 parts of 1-iodopropane and the whole is stirred and heated under reflux for 47 hours. Then a second portion of 4 parts of 1-iodopropane is added and stirring and heating under reflux for a further 20 hours and 20 minutes. The reaction mixture is cooled and filtered. The filtrate is washed with water, dried and evaporated in vacuo. From the oily free base, the hydrochloride salt in 1,1'-oxybisethane is prepared in the usual manner. The precipitated solid salt is filtered off and dried to give 3.5 parts of N- (4-chlorophenyl) -N- (1-propyl-4-piperidinyl) benzeneacetamide, hydrochloride, mp 233.5 ° C.

Eksempel 43Example 43

Efter fremgangsmåden i Eksempel 42 og under anvendelse af en ækvivalent mængde af henholdsvis en passende iodalkan og et passende N-aryl-N-(4-piperidinyl)arylacetamid i stedet for de deri anvendte 1-iodpropan og N-(4-chlorphenyl)-N-(4-piperidinyl)-benzenacetamid opnås de følgende forbindelser: N-(2,6-dimethylphenyl)-N-(1-ethyl-4-piperidinyl)-2-thiophen-acetamid,hydrochlorid, smeltepunkt 258 °Cf N-(4-chlorphenyl)-N-(l-ethyl-4-piperidinyl)-2-thiophenacet-amid,hydrochlorid, smeltepunkt 220,5 °C; 41 150478 N-(4-chlorphenyl)-N-(1-ethyl-4-piperidinyl)benzenacetamid, hydrochloric!, smeltepunkt 215 °Cj 4-chlor-N-(4-chlorphenyl)-N-(1-ethyl-4-piperidinyl)benzen-acetamid,hydrochlorid; smeltepunkt 224 °C og N-(4-chlorphenyl)-N-(l-propyl-4-piperidinyl)-2-thiophen-acetamid, smeltepunkt 241 °C.Following the procedure of Example 42 and using an equivalent amount of a suitable iodine alkane and a suitable N-aryl-N- (4-piperidinyl) arylacetamide, respectively, in place of the 1-iodopropane and N- (4-chlorophenyl) used therein, respectively. N- (4-piperidinyl) -benzeneacetamide is obtained from the following compounds: N- (2,6-dimethylphenyl) -N- (1-ethyl-4-piperidinyl) -2-thiophene-acetamide, hydrochloride, m.p. 258 ° C (4-chlorophenyl) -N- (1-ethyl-4-piperidinyl) -2-thiophenacetamide, hydrochloride, mp 220.5 ° C; N- (4-chlorophenyl) -N- (1-ethyl-4-piperidinyl) benzeneacetamide, hydrochloricyl, mp 215 ° C 4-chloro-N- (4-chlorophenyl) -N- (1-ethyl-4) piperidinyl) benzene-acetamide hydrochloride; mp 224 ° C and N- (4-chlorophenyl) -N- (1-propyl-4-piperidinyl) -2-thiophene acetamide, mp 241 ° C.

Eksempel 44Example 44

En blanding af 4,5 dele N-(l-cyclopentyl-4-piperidinyl)-2-pyrimidinamin, 3,4 dele 3-methylbenzenacetylchlorid, 2 dele natriumcarbonat og 180 dele dimethylbenzen omrøres og opvarmes under tilbagesvaling i 17 timer. Yderligere 9 dele 3-methylbenzenacetylchlorid tilsættes dråbevis. Efter endt tilsætning fortsættes omrøring i 67 timer ved tilbagesvalingstemperatur. Reaktionsblandingen afkøles, vand tilsættes, og lagene skilles.A mixture of 4.5 parts of N- (1-cyclopentyl-4-piperidinyl) -2-pyrimidinamine, 3.4 parts of 3-methylbenzeneacetyl chloride, 2 parts of sodium carbonate and 180 parts of dimethylbenzene is stirred and heated under reflux for 17 hours. An additional 9 parts of 3-methylbenzeneacetyl chloride are added dropwise. After the addition is complete, stirring is continued for 67 hours at reflux temperature. The reaction mixture is cooled, water is added and the layers are separated.

Den organiske fase ekstraheres med en fortyndet saltsyreopløsning. De forenede vandige faser udvaskes med benzen og gøres alkalisk med en fortyndet natriumhydroxidopløsning under afkøling i et isbad. Produktet ekstraheres 2 gange med trichlor-methan. De forenede ekstrakter tørres, filtreres og inddampes. Remanensen omdannes til oxalatsaltet i 2-propanol. Saltet fra-filtreres og udkrystalliseres 2 gange, først fra ethanol og dernæst fra methanol til dannelse af 1 del N-(l-cyclopentyl-4-piperidinyl)-3-methyl-N-(2-pyrimidinyl)benzenacetamid, ethandioat, smeltepunkt 204,1 °C.The organic phase is extracted with a dilute hydrochloric acid solution. The combined aqueous phases are washed with benzene and made alkaline with a dilute sodium hydroxide solution while cooling in an ice bath. The product is extracted twice with trichloromethane. The combined extracts are dried, filtered and evaporated. The residue is converted to the oxalate salt in 2-propanol. The salt is filtered off and crystallized twice, first from ethanol and then from methanol to give 1 part N- (1-cyclopentyl-4-piperidinyl) -3-methyl-N- (2-pyrimidinyl) benzeneacetamide, ethanedioate, m.p. 204 -1 ° C.

Eksempel 45Example 45

Efter fremgangsmåden i Eksempel 44 og under anvendelse af ækvivalente mængder af henholdsvis en passende N-aryl-4-piperidinamin og et passende arylacetylchlorid som udgangsmaterialer opnås de følgende forbindelser i baseform eller éfter behandling med den passende syre i syreadditionssaltform: 42 150478 ~cx ^ 1 λ—/ N-C-CH,-ArxFollowing the procedure of Example 44 and using equivalent amounts of a suitable N-aryl-4-piperidinamine and a suitable arylacetyl chloride, respectively, as starting materials, the following compounds are obtained in base form or after treatment with the appropriate acid in acid addition salt form: 42 150478 ~ cx1 λ— / NC-CH, -Arx

Ar L Ar Ar1 base- eller saltform smp.Ar L Ar Ar1 base or salt form m.p.

V 3-pyridinyl CgH,- (E)-2-butendioat 219,6 °CV 3-pyridinyl CgH, - (E) -2-butenedioate 219.6 ° C

3-pyridinyl 3-CH^-Cgir (E)-2-butendioat 250,3 °C y. 2-pyridinyl 3-Cl-CgH4 (COOH)2 205,9 °C3-pyridinyl 3-CH 2 -Cgir (E) -2-butenedioate 250.3 ° C y. 2-pyridinyl 3-Cl-CgH 4 (COOH) 2 205.9 ° C

”y- 2-pyridinyl 3-CH3-CgH4 base 107,8 °CΓ-2-pyridinyl 3-CH 3 -C 3 H 4 base 107.8 ° C

j^- 2-pyridinyl 4-Cl-CgH^ base 119,2eC2 - 2-Pyridinyl 4-C1-C6 H3 base 119.2 ° C

Q- 2-pyridinyl 2-thienyl base 129,4°CQ-2-pyridinyl 2-thienyl base 129.4 ° C

2-pyridinyl CgHg base 108,8°C2-pyridinyl CgHg base 108.8 ° C

2-pyrimidinyl CgH5 (COOH)2 223,5eC2-pyrimidinyl C 9 H 5 (COOH) 223.5 ° C

(CH3)2-CH- 3-pyridinyl CgH5 base 129,4eC(CH3) 2-CH-3-pyridinyl CgH5 base 129.4 ° C

(CH3)2-CH- 3-pyridinyl 3-Cl-CgH^ base 117,7eC(CH3) 2-CH-3-pyridinyl 3-C1-C6 H3 base 117.7 ° C

(CH3)2-CH- 3-pyridinyl 4-Cl-CgH^ base 146,6°C(CH3) 2-CH-3-pyridinyl 4-C1-C6 H6 base 146.6 ° C

(CH3)2-CH- 3-pyridinyl 2-thienyl base 126, 7®C(CH3) 2-CH-3-pyridinyl 2-thienyl base 126, 7 ° C

(CH3)2-CH- 3-pyridinyl 3-CH3-C6H4 base 10°β(:(CH3) 2-CH-3-pyridinyl 3-CH3-C6H4 base 10 ° β (:

(CH3)2-CH- 2-pyridinyl 3-Cl-Cgt^ base 102,6°C(CH 3) 2-CH-2-pyridinyl 3-C 1 -C 8 base 102.6 ° C

(CH3)2-CH- 2-pyridinyl CgH5 base 72,1°C(CH3) 2-CH-2-pyridinyl CgH5 base 72.1 ° C

(CH3)2-CH- 2-pyridinyl 4-Cl-C6H4 base 83,3°C(CH3) 2-CH-2-pyridinyl 4-C1-C6H4 base 83.3 ° C

(CH3)2~CH- 2-pyridinyl 3-CH3-C6H4 (COOH)2 190,6eC(CH3) 2 ~ CH-2-pyridinyl 3-CH3-C6H4 (COOH) 2 190.6 ° C

(CH3)2-CH- 2-pyridinyl 2-thienyl (COOH)2 196,1°C(CH 3) 2-CH-2-pyridinyl 2-thienyl (COOH) 2 196.1 ° C

(CH3)2-CH- 2-pyrimidinyl 4-Cl-CgH4 (COOH)2 195,7°C(CH 3) 2-CH-2-pyrimidinyl 4-C 1 -C 3 H 4 (COOH) 2 195.7 ° C

Eksempel 46 .Example 46

150478 4343

Til en omrørt blanding af 4,4 dele 1-(1-methylethyl)-N-phenyl-4-piperidinamin, 5,3 dele natriumcarbonat og 180 dele benzen sættes dråbevis 5 dele benzenacetylchlorid. Efter endt tilsætning fortsættes omrøring natten over under tilbagesvaling. Reaktionsblandingen afkøles, udvaskes med vand, natriumhydrogen-carbonatopløsning og atter med vand efter hinanden, tørres , filtreres og inddampes. Remanensen omdannes til hydrochloridsaltet i 2,2'-oxybispropan og 2-propanol. Det dannede salt frafiltreres og udkrystalliseres fra en blanding af 2-propanol og 2,2'-oxybispropan til dannelse af 2,5 dele N-[1-(1-methylethyl)-4-piperidinyl]-N-phenylbenzenacetamid,hydrochlorid, smeltepunkt 184,4 °C.To a stirred mixture of 4.4 parts of 1- (1-methylethyl) -N-phenyl-4-piperidinamine, 5.3 parts of sodium carbonate and 180 parts of benzene is added dropwise 5 parts of benzeneacetyl chloride. After the addition is complete, stirring is continued overnight under reflux. The reaction mixture is cooled, washed with water, sodium hydrogen carbonate solution and again with water successively, dried, filtered and evaporated. The residue is converted to the hydrochloride salt in 2,2'-oxybispropane and 2-propanol. The resulting salt is filtered off and crystallized from a mixture of 2-propanol and 2,2'-oxybispropane to give 2.5 parts of N- [1- (1-methylethyl) -4-piperidinyl] -N-phenylbenzeneacetamide, hydrochloride, m.p. 184.4 ° C.

Eksempel 47.Example 47.

Efter fremgangsmåden i Eksempel 46 og under anvendelse af ækvivalente mængder af henholdsvis en passende N-aryl-4-piperidin-amin og et passende arylacetylchlorid som udgangsmaterialer opnås de følgende forbindelser i baseform eller efter behandling med den passende syre i syreadditionssaltform: i 2Following the procedure of Example 46 and using equivalent amounts of a suitable N-aryl-4-piperidine amine and a suitable arylacetyl chloride as starting materials, respectively, the following compounds are obtained in base form or after treatment with the appropriate acid in acid addition salt form: in 2

Ar T av Av1 base- eller L Ar Ar saltform smp*Ar T of Av1 base or L Ar Ar salt form m.p.

(CH3)2-CH- CgH5 3-CH3-CgH4 HC1 173,6 °C(CH3) 2-CH-CgH5 3-CH3-CgH4 HCl 173.6 ° C

(CH3)2-CH- CgH5 3-Cl-CgH4 HC1 204,8 °C(CH3) 2-CH-CgH5 3-Cl-CgH4 HCl 204.8 ° C

(CH3)2-CH- CgHg 2-thienyl (E)-2-butendioab168#λ °c(CH3) 2-CH-CgHg 2-thienyl (E) -2-butenedioab168 # λ ° c

CH3 2,6-(CH3)2-CgH3 CgHg base 95,5 °CCH3 2.6- (CH3) 2-CgH3 CgHg base 95.5 ° C

CH- 4-Cl-CcH. CcH base 115 °CCH-4-Cl-CcH. CcH base 115 ° C

C2H5 4-Cl-CgH4 3-OCH3-CgH4 base 90,7 °CC2H5 4-Cl-CgH4 3-OCH3-CgH4 base 90.7 ° C

nC3H7 2,6-(CH3)2-CgH3 2-thienyl (C00H)2 153 °CnC3H7 2.6- (CH3) 2-CgH3 2-thienyl (COH) 2 153 ° C

44 150478 —————ι * x base- eller { L _Ar__Ax sgltform__smp' j44 150478 ————— ι * x base or {L _Ar__Ax sgltform__smp 'j

nC3H? 2,6-(CH3)2-c6H3 c6h5 (COOH)2 l6l°C JnC3H? 2.6- (CH3) 2-c6H3 c6h5 (COOH) 216 ° C J

CH2=CH-CH2 4-Cl-C6H4 2-thienyl HC1 ZZtf5°CCH2 = CH-CH2 4-Cl-C6H4 2-thienyl HCl ZZtf5 ° C

o ' 2-thienyl base j 119eC Io '2-thienyl base j 119eC I

| ^ 3-pyridinyl 4-Cl-C^H^ base 149,9*0| ^ 3-Pyridinyl 4-Cl-C ^ H ^ base 149.9 * 0

Q. 3-pyridinyl 3-Cl-C^H^ 2HCl,l/2H20 236V6*CQ. 3-Pyridinyl 3-Cl-C ^H ^₂HCl, 1 / 2H₂O 236V6 * C

j 3-pyridinyl 2-thienyl base 159,8°G3-pyridinyl 2-thienyl base 159.8 ° G

Eksempel 48«Example 48 «

En opslæmning af 1,25 dele natriumamid i 56 dele benzen omrøres under nitrogenatmosfære og opvarmes til en temperatur på 40 °C. Derpå tilsættes dråbevis en opløsning af 6 dele N-(4-chlorphenyl)-1-(1-methylethyl)-4-piperidinamin i 56 dele benzen. Efter endt tilsætning omrøres det hele og holdes opvarmet under tilbagesvaling i 16 timer og 45 minutter. Blandingen afkøles til 25 °C, og der tilsættes en blanding af 7,8 dele 3,4-dichlorbenzenacetylchlorid i 88 dele benzen. Efter omrøring og opvarmning under tilbagesvaling i yderligere 2 timer, afkøles reaktionsblandingen, og 80 dele vand tilsættes. Det hele gøres sur med en fortyndet saltsyreopløsning. Den vandige syrefase gøres alkalisk med natriumhydroxidopløsning, og den frie base ekstraheres med trichlormethan. Ekstrakten tørres, filtreres og inddampes. Remansen opløses i en blanding af 80 dele 1,1'-oxybisethan og 120 dele hexan. Opløsningen afkøles natten over ved -10 °C, filtreres fra nogle urenheder,og filtratet inddampes igen. Remanensen opløses i 120 dele l,l'-oxybisethan, behandles med aktiveret trækul, filtreres og inddampes. Denne remanens udkrystalliseres fra hexan ved -10 °C til dannelse af 2,2 dele 3,4-dichlor-N-(4-chlorphenyl)-N-[1-(1-methylethyl)-4-piperidinyl]-benzenacetamid, smeltepunkt 101,7 °C.A slurry of 1.25 parts of sodium amide in 56 parts of benzene is stirred under a nitrogen atmosphere and heated to a temperature of 40 ° C. Then a solution of 6 parts of N- (4-chlorophenyl) -1- (1-methylethyl) -4-piperidinamine in 56 parts of benzene is added dropwise. After the addition is complete, the whole is stirred and kept under reflux for 16 hours and 45 minutes. The mixture is cooled to 25 ° C and a mixture of 7.8 parts of 3,4-dichlorobenzene acetyl chloride in 88 parts of benzene is added. After stirring and heating at reflux for a further 2 hours, the reaction mixture is cooled and 80 parts of water are added. Make it all acidic with a dilute hydrochloric acid solution. The aqueous acid phase is made alkaline with sodium hydroxide solution and the free base is extracted with trichloromethane. The extract is dried, filtered and evaporated. The residue is dissolved in a mixture of 80 parts of 1,1'-oxybisethane and 120 parts of hexane. The solution is cooled overnight at -10 ° C, filtered from some impurities and the filtrate is evaporated again. The residue is dissolved in 120 parts of 1,1'-oxybisethane, treated with activated charcoal, filtered and evaporated. This residue is crystallized from hexane at -10 ° C to give 2.2 parts of 3,4-dichloro-N- (4-chlorophenyl) -N- [1- (1-methylethyl) -4-piperidinyl] benzeneacetamide, m.p. 101.7 ° C.

Eksempel 49 150478 45Example 49

Efter fremgangsmåden i Eksempel 48 og under anvendelse af ækvivalente mængder af henholdsvis en passende N-aryl-4-piperidin-amin og et passende arylacetylchlorid som udgangsmaterialer opnås de følgende forbindelser i baseform eller efter behandling med den passende syre i syreadditionssaltform: 4-brom-N-(4-chlorphenyl)-N-[1-(1-methylethyl)-4-piperidinyl]-benzenacetamid, smeltepunkt 118,1 °C; 4-chlor-N-(2,6-dimethylphenyl)-N-[1-(1-methylethyl)-4-piperidinyl]-benzenacetamid,hydrochlorid, smeltepunkt 268,2 °C og N-(4-chlorphenyl)-4-(1-methylethyl)-N-[1-(1-methylethyl)-4-piperidinyl]benzenacetamid, smeltepunkt 104,9 °C.Following the procedure of Example 48 and using equivalent amounts of a suitable N-aryl-4-piperidine amine and a suitable arylacetyl chloride, respectively, as starting materials, the following compounds are obtained in base form or after treatment with the appropriate acid in acid addition salt form: N- (4-chlorophenyl) -N- [1- (1-methylethyl) -4-piperidinyl] benzeneacetamide, m.p. 118.1 ° C; 4-Chloro-N- (2,6-dimethylphenyl) -N- [1- (1-methylethyl) -4-piperidinyl] -benzeneacetamide, hydrochloride, m.p. 268.2 ° C and N- (4-chlorophenyl) -4 - (1-methylethyl) -N- [1- (1-methylethyl) -4-piperidinyl] benzeneacetamide, m.p. 104.9 ° C.

Eksempel 50.Example 50

5 dele 4-chlor-N-(4-chlorphenyl)-N-[l-(l-methylethyl)-4-piperidinyl]benzenacetamid opløses i en blanding af 60 dele 1,1'-oxybisethan og 16 dele 2-propanon. Den resulterende opløsning gøres sur med et overskud af 2-propanol, som forud er mættet med gasformig hydrogenchlorid. Det udfældede salt frafiltreres og tørres til dannelse af 7,5 dele 4-chlor-N-(4-chlorphenyl)-N-[1-(1-methylethyl)-4-piperidinyl]benzenacetamid,hydrochloridj smeltepunkt 266,6 °C.5 parts of 4-chloro-N- (4-chlorophenyl) -N- [1- (1-methylethyl) -4-piperidinyl] benzeneacetamide are dissolved in a mixture of 60 parts of 1,1'-oxybisethane and 16 parts of 2-propanone. The resulting solution is acidified with an excess of 2-propanol, which is previously saturated with gaseous hydrogen chloride. The precipitated salt is filtered off and dried to give 7.5 parts of 4-chloro-N- (4-chlorophenyl) -N- [1- (1-methylethyl) -4-piperidinyl] benzeneacetamide, hydrochloride, mp 266.6 ° C.

Eksempel 51Example 51

Fra 6 dele N-[1-(1-methylethyl)-4-piperidinyl]-N-phenyl- 2-thiophenacetamid, (E)-2-butendioat frigøres den frie base på konventionel måde med en fortyndet natriumhydroxidopløsning. Produktet ekstraheres med trichlormethan. Ekstrakten udvaskes med vand, tørres, filtreres og inddampes. Remanensen omdannes til ethan-dioatet i 2-propanol. Saltet frafiltreres og tørres til dannelse af 3,2 dele N-[1-(1-methylethyl)-4-piperidinyl]-N-phenyl-2-thio-phenacetamid,ethandioat,smeltepunkt 167,4 °C.From 6 parts of N- [1- (1-methylethyl) -4-piperidinyl] -N-phenyl-2-thiophenacetamide, (E) -2-butenedioate, the free base is released in a conventional manner with a dilute sodium hydroxide solution. The product is extracted with trichloromethane. The extract is washed with water, dried, filtered and evaporated. The residue is converted to the ethanedioate in 2-propanol. The salt is filtered off and dried to give 3.2 parts of N- [1- (1-methylethyl) -4-piperidinyl] -N-phenyl-2-thio-phenacetamide, ethanedioate, mp 167.4 ° C.

Eksempel 52 150478 46Example 52 46

Fra en vandig opløsning af 2,8 dele N-(2,6-dimethylphenyl)-N-(l-propyl-4-piperidinyl)-2-thiophenacetamid,dihydrochlorid frigøres den frie base ved alkalisering med natriumhydrogen-carbonatopløsning. Den frie base ekstraheres med l,l'-oxybis-ethan. Ekstrakten tørres og inddampes. Den olieagtige remanens opløses i 56 dele hexan, og efter afkøling til -10 °C udfældes den faste frie base. Den frafiltreres og tørres til dannelse af 1,6 dele N-(2,6-dimethylphenyl)-N-(l-propyl-4-piperidinyl)-2-thiophenacetamid, smeltepunkt 62,5 °C.From an aqueous solution of 2.8 parts of N- (2,6-dimethylphenyl) -N- (1-propyl-4-piperidinyl) -2-thiophenacetamide, dihydrochloride is released from the free base by alkalization with sodium hydrogen carbonate solution. The free base is extracted with 1,1'-oxybis-ethane. The extract is dried and evaporated. The oily residue is dissolved in 56 parts of hexane and after cooling to -10 ° C the solid free base is precipitated. It is filtered off and dried to give 1.6 parts of N- (2,6-dimethylphenyl) -N- (1-propyl-4-piperidinyl) -2-thiophenacetamide, mp 62.5 ° C.

Eksempel 53Example 53

Fra 3,9 dele N-(l-cyclopentyl-4-piperidinyl)-3-methyl-N-(3-pyridiny 1) benzenacetamid ,(E) -2-butendioat frigøres den frie base på konventionel måde med en fortyndet natriumhydroxidopløsning.From 3.9 parts of N- (1-cyclopentyl-4-piperidinyl) -3-methyl-N- (3-pyridiny 1) benzeneacetamide, (E) -2-butenedioate, the free base is conventionally released with a dilute sodium hydroxide solution.

Efter ekstraktion med 2,2'-oxybispropan vaskes ekstrakten med vand, tørres, filtreres og inddampes. Remanensen omdannes til ethan-dioatet i ethanol. Saltet frafiltreres og udkrystalliseres fra en blanding af ethanol og 2,2'-oxybispropan til dannelse af 3 dele N-(l-cyclopentyl-4-piperidinyl)-3-methyl-N-(3-pyridinyl)-benzenacetamid, ethandioat, smeltepunkt 192,6°c.After extraction with 2,2'-oxybispropane, the extract is washed with water, dried, filtered and evaporated. The residue is converted to the ethanedioate in ethanol. The salt is filtered off and crystallized from a mixture of ethanol and 2,2'-oxybispropane to give 3 parts of N- (1-cyclopentyl-4-piperidinyl) -3-methyl-N- (3-pyridinyl) benzeneacetamide, ethanedioate, m.p. 192.6 ° C.

Eksempel 54Example 54

Til en omrørt blanding af 5,5 dele 4-(methoxymethyl)-l-(l-méthylethyl)-N-phenyl-4-piperidinamin i 56 dele benzen sættes dråbevis en opløsning af 13,8 dele benzenacetylchlorid i 45 dele benzen ved 26 - 32 °C. Efter endt tilsætning fortsættes omrøring først i 1 time ved 26 - 32 °C og dernæst i yderligere 3,60 timer ved 38 - 55 °C. Efter afkøling frafiltreres det udfældede produkt og omdannes til hydrochloridsaltet i en blanding af 2-propanol og 2-propanon (5:1 efter volumen). Saltet frafiltreres og opløses i absolut ethanol. Efter henstand i 72 timer ved stuetemperatur frafiltreres det udfældede produkt, udvaskes med en lille smule 2-propanon og tørres til dannelse af 1,05 dele N-[4-(methoxymethyl)-l-(l-methylethyl)-4-piperidinyl]-N-phenylbenzenacetamid,hydrochlorid, smeltepunkt 249,1 °C.To a stirred mixture of 5.5 parts of 4- (methoxymethyl) -1- (1-methylethyl) -N-phenyl-4-piperidinamine in 56 parts of benzene is added dropwise a solution of 13.8 parts of benzeneacetyl chloride in 45 parts of benzene at 26 - 32 ° C. After the addition is complete, stirring is first continued for 1 hour at 26 - 32 ° C and then for an additional 3.60 hours at 38 - 55 ° C. After cooling, the precipitated product is filtered off and converted to the hydrochloride salt in a mixture of 2-propanol and 2-propanone (5: 1 by volume). The salt is filtered off and dissolved in absolute ethanol. After standing for 72 hours at room temperature, the precipitated product is filtered off, washed with a small amount of 2-propanone and dried to give 1.05 parts of N- [4- (methoxymethyl) -1- (1-methylethyl) -4-piperidinyl] -N-phenylbenzeneacetamide, hydrochloride, mp 249.1 ° C.

Eksempel 55 150478 47Example 55 47

Til en omrørt blanding af 7,5 dele N-(4-chlorphenyl)-1-(1-methylethyl)-4-piperidinamin og 80 dele 4-methyl-2-pentanon sættes dråbevis 9 dele [4-(2-chlor-2-oxoethyl)phenyl]ethyl-carbonat. Efter endt tilsætning opvarmes det hele under tilbagesvaling, og omrøring fortsættes i 1 time ved tilbagesvalings-temparatur. Efter afkøling frafiltreres det udfældede produkt og omrøres i 30 minutter i en blanding af alkalisk vand og trichlor-methan. Lagene skilles. Den organiske fase tørres, filtreres og inddampes. Den olieagtige remanens renses ved søjle-chromatografi over silicagel under anvendelse af en blanding af trichlormethan og methanol (90:10 efter volumen) som elueringsmiddel. De rene fraktioner samles, og elueringsmidlet afdampes til dannelse af 5,5 dele j 4-[2- £(4-chlorphenyl)-[l-(l-methylethyl)-4-piperidinyl]aminoj -2-oxoethyl]phenylj ethylcarbonat som olieagtig remanens.To a stirred mixture of 7.5 parts of N- (4-chlorophenyl) -1- (1-methylethyl) -4-piperidinamine and 80 parts of 4-methyl-2-pentanone is added dropwise to 9 parts [4- (2-chloro-phenyl)]. 2-oxoethyl) phenyl] ethyl carbonate. After the addition is complete, the whole is heated to reflux and stirring is continued for 1 hour at reflux temperature. After cooling, the precipitated product is filtered off and stirred for 30 minutes in a mixture of alkaline water and trichloromethane. The teams are separated. The organic phase is dried, filtered and evaporated. The oily residue is purified by column chromatography over silica gel using a mixture of trichloromethane and methanol (90:10 by volume) as eluent. The pure fractions are collected and the eluent is evaporated to give 5.5 parts of 4- [2- [(4-chlorophenyl) - [1- (1-methylethyl) -4-piperidinyl] amino] -2-oxoethyl] phenyl] ethyl carbonate as oily residue.

En blanding af 5,5 dele £ 4-[2- ^ (4-chlorphenyl)[1-(1-methylethyl)-4-piperidinyl]aminoj -2-oxoethyl]phenylj ethylcarbonat og 50 dele natriumhydroxidopløsning 10% omrøres i 90 minutter ved 45 °C. Reaktionsblandingen afkøles til stuetemperatur og gøres sur med eddikesyre til pH-værdi 5,5 - 6. Produktet ekstraheres med trichlormethan. Ekstrakten tørres, filtreres og inddampes. Den olieagtige remanens renses ved søjle-chromatografi over silicagel under anvendelse af en blanding af trichlormethan og methanol (80:20 efter volumen) som elueringsmiddel. De rene fraktioner samles, og elueringsmidlet afdampes.A mixture of 5.5 parts of 4- [2- [(4-chlorophenyl) [1- (1-methylethyl) -4-piperidinyl] amino] -2-oxoethyl] phenyl] ethyl carbonate and 50 parts of sodium hydroxide solution 10% is stirred for 90 minutes at 45 ° C. The reaction mixture is cooled to room temperature and acidified with acetic acid to pH 5.5 - 6. The product is extracted with trichloromethane. The extract is dried, filtered and evaporated. The oily residue is purified by column chromatography over silica gel using a mixture of trichloromethane and methanol (80:20 by volume) as eluent. The pure fractions are collected and the eluent is evaporated.

Den olieagtige remanens omdannes til hydrochloridsaltet i 4-methyl-2-pentanon. Saltet frafiltreres og tørres i vakuum i 12 timer ved 60 °C til dannelse af 1,9 dele N-(4-chlorphenyl)-4-hydroxy-N-[1-(1-methylethyl)-4-piperidinyl]benzenacetamid,mono-hydrochlorid, smeltepunkt 242,9 °C.The oily residue is converted to the hydrochloride salt in 4-methyl-2-pentanone. The salt is filtered off and dried in vacuo for 12 hours at 60 ° C to give 1.9 parts of N- (4-chlorophenyl) -4-hydroxy-N- [1- (1-methylethyl) -4-piperidinyl] benzeneacetamide, mono hydrochloride, mp 242.9 ° C.

48 15047848 150478

Eksempel 56Example 56

En blanding af 8 dele 2-propanon og 9,9 dele N-(4-chlorphe-nyl)N-(4-piperidinyl)-benzenacetamid, hydrochlorid i 160 dele methanol hydrogeneres ved normalt tryk og stuetemperatur med 2 dele palladium-på-trækul katalysator 10%.A mixture of 8 parts of 2-propanone and 9.9 parts of N- (4-chlorophenyl) N- (4-piperidinyl) benzeneacetamide, hydrochloride in 160 parts of methanol is hydrogenated at normal pressure and room temperature with 2 parts of palladium on top. charcoal catalyst 10%.

Efter at den beregnede mængde hydrogen er optaget, frafil-treres katalysatoren, og filtratet inddampes. Remanensen opsamles i en blandihg af 2-propanon og 1,1'-oxybispropan og fældes som hydrochloridsaltet. Produktet frafiltreres og tørres til opnåelse af et udbytte på 6,3 dele N-(4-chlorphenyl)-N-[l-(l-methylethyl)--4-piperidinyl]benzenacetamid, hydrochlorid, smp. 262,3°C.After the calculated amount of hydrogen is taken up, the catalyst is filtered off and the filtrate is evaporated. The residue is collected in a mixture of 2-propanone and 1,1'-oxybispropane and precipitated as the hydrochloride salt. The product is filtered off and dried to yield 6.3 parts of N- (4-chlorophenyl) -N- [1- (1-methylethyl) -4-piperidinyl] benzeneacetamide, hydrochloride, m.p. 262.3 ° C.

Claims (2)

4 9 1504784 9 150478 1. Analogifremgangsmåde til fremstilling af N-aryl-N-(4- piperidinyl)arylacetamidderivater med den almene formel \-' N-C-CH.-ArX ir eller farmaceutisk acceptable syreadditionssalte deraf, hvori: L betegner hydrogen, (C^-C^q)alkyl, (C3-Cg)cycloalkyl, (C3“Cg)cycloalkyl-(C^-Cg)alkyl eller (C^-Cg)alkenyl, Ar betegner phenyl, mono- eller di-substitueret phenyl, pyridyl eller 2-pyrimidyl, hvori enhver af substituenterne i den mono- eller di-substituerede phenyl uafhængigt af hinanden er halogen eller (C1-Cg)alkyl, Ar"*- betegner phenyl, mono- eller di-substi tueret phenyl eller 2-thienyl, hvori enhver af substituenterne i den mono- eller di-substituerede phenyl uafhængigt af hinanden betegner halogen, (C^-Cg)alkyl, hydroxy eller (ci“C6)sikyioxy/ X betegner hydrogen eller (C-^-Cg) alkyloxymethyl, og under den forudsætning, at L er forskellig fra (Cg-Cg)cycloal-kyl, når Ar og Ar"*" begge er phenyl eller substitueret phenyl, og X er hydrogen, KENDETEGNET ved, at man a) hydrolyserer en forbindelse med den almene formel ^-Cglalkyl-O-C-N V O (IV) '-' N-C-CH0-Ar1 IAn analogous process for the preparation of N-aryl-N- (4-piperidinyl) arylacetamide derivatives of the general formula - NC-CH.-ArX ir or pharmaceutically acceptable acid addition salts thereof, wherein: L represents hydrogen, (C q) alkyl, (C 3 -C 8) cycloalkyl, (C 3 -C 8) cycloalkyl (C 1 -C 8) alkyl or (C 1 -C 6) alkenyl, Ar represents phenyl, mono- or di-substituted phenyl, pyridyl or 2- pyrimidyl wherein each of the substituents of the mono- or di-substituted phenyl is independently halogen or (C 1 -C 6) alkyl, Ar "- represents phenyl, mono- or di-substituted phenyl or 2-thienyl, wherein any of the substituents of the mono- or di-substituted phenyl independently of one another denotes halo, (C 1 -C 6) alkyl, hydroxy or (c 1 -C 6) cycloxy / X represents hydrogen or (C 1 -C 6) alkyloxymethyl, and below it provided that L is different from (Cg-Cg) cycloalkyl when Ar and Ar "*" are both phenyl or substituted phenyl and X is hydrogen, FEATURED by a) hydrolyzing a compound of the general formula C-Cglalkyl-O-C-N V O (IV) '-' N-C-CHO-Arl I 2 Ar hvori Ar, Ar1 og X har den ovenfor anførte betydning, i et surt eller basisk vandigt medium til fremstilling af en forbindelse med formlen 150478 Of* . '-' N-C-CH_-ArX I 2 Ar hvori Ar, Ar1 og X har de ovenfor anførte betydninger, hvilken forbindelse (I-a) dernæst om ønsket omsættes med en forbindelse med formlen I/hf, hvori har samme betydning som L, men dog er forskellig fra hydrogen, og Y betegner en reaktionsdygtig gruppe, fortrinsvis et halogenatom, idet omsætningen udføres i et reaktionsinert organisk opløsningsmiddel, fortrinsvis i nærværelse af en base, til fremstilling af en forbindelse, som har formlen 1ΛΛ/ο V-YVc-CH.-Ar1 II-°> I 2 Ar . 1 1 hvori L , Ar, Ar og X har de ovenfor anførte betydninger, eller b) til fremstilling af en forbindelse med den almene formel aTY ? \_/ N-C-CH^-Ar1 (1-c) L 1. hvori Ar, Ar og X har de ovenfor anførte betydninger, og L betyder (C^C10)alkyl, (-Cg)cycloalkyl eller (C^-Cg)cycloalkyl-(Ci-Cgjelkyl, og carbonatomet, som er bundet til piperidinnitrogenet, bærer i det mindste 1 hydrogenatom, katalytisk hydrogene-rer en blanding af et til alkoholen L -OH svarende aldehyd eller keton og en forbindelse med formlen (I-a), i nærværelse af en passende katalysator, eller2 Ar wherein Ar, Ar 1 and X have the meaning given above, in an acidic or basic aqueous medium to prepare a compound of formula 150478 Of *. '-' NC-CH_-ArX I 2 Ar wherein Ar, Ar1 and X have the meanings set forth above, which compound (Ia) is then, if desired, reacted with a compound of formula I / hf, having the same meaning as L but is different from hydrogen and Y represents a reactive group, preferably a halogen atom, the reaction being carried out in a reaction inert organic solvent, preferably in the presence of a base, to prepare a compound having the formula 1ΛΛ / ο V-YVc-CH. -Ar1 II- °> I 2 Ar. 1 in which L, Ar, Ar and X have the meanings set forth above, or b) for the preparation of a compound of the general formula aTY? Wherein: Ar, Ar and X have the meanings given above and L is (C 1 -C 10) alkyl, (-C 8) cycloalkyl or (C 1 -C 6) ) cycloalkyl (C 1 -C 18 gelkyl), and the carbon attached to the piperidine nitrogen carries at least 1 hydrogen atom, catalytically hydrogenates a mixture of an aldehyde or ketone corresponding to the alcohol and a compound of formula (Ia), in the presence of a suitable catalyst, or
DK427876A 1975-09-23 1976-09-22 METHOD OF ANALOGY FOR THE PREPARATION OF N-ARYL-N- (4-PIPERIDYL) -ARYLACETAMIDE DERIVATIVES DK150478C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK453484A DK153474C (en) 1975-09-23 1984-09-21 METHOD OF ANALOGY FOR THE PREPARATION OF N-ARYL-N- (4-PIPERIDYL) -ARYLACETAMIDE DERIVATIVES

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US61513175 1975-09-23
US71375676A 1976-08-12 1976-08-12
US71375676 1976-08-12

Publications (3)

Publication Number Publication Date
DK427876A DK427876A (en) 1977-03-24
DK150478B true DK150478B (en) 1987-03-09
DK150478C DK150478C (en) 1987-10-05

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK427876A DK150478C (en) 1975-09-23 1976-09-22 METHOD OF ANALOGY FOR THE PREPARATION OF N-ARYL-N- (4-PIPERIDYL) -ARYLACETAMIDE DERIVATIVES

Country Status (29)

Country Link
JP (1) JPS6016417B2 (en)
AT (1) AT363935B (en)
AU (1) AU510029B2 (en)
BG (1) BG27543A3 (en)
CA (1) CA1068271A (en)
CH (1) CH628623A5 (en)
CS (1) CS222663B2 (en)
DE (1) DE2642856A1 (en)
DK (1) DK150478C (en)
ES (1) ES451768A1 (en)
FI (1) FI61482C (en)
FR (1) FR2325377A1 (en)
GB (1) GB1539473A (en)
GR (1) GR58469B (en)
HU (1) HU172964B (en)
IE (1) IE43802B1 (en)
IL (1) IL50522A (en)
IT (1) IT1073893B (en)
LU (1) LU75837A1 (en)
NL (1) NL187267C (en)
NO (1) NO147672C (en)
NZ (1) NZ181972A (en)
PH (1) PH12497A (en)
PL (2) PL117323B1 (en)
PT (1) PT65631B (en)
RO (1) RO70079A (en)
SE (1) SE427839B (en)
SU (1) SU747424A3 (en)
YU (1) YU39973B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (en) * 1986-05-08 1987-11-13 株式会社ヘキトク Line system for manufacturing smoked roof tile
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
ES2400710T3 (en) 2007-04-23 2013-04-11 Janssen Pharmaceutica, N.V. Tia (dia) zoles as fast dissociation dopamine 2 receptor antagonists
JP2010525013A (en) * 2007-04-23 2010-07-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
US8906921B2 (en) 2007-04-23 2014-12-09 Janssen Pharmaceutica Nv 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
WO2010000456A1 (en) 2008-07-03 2010-01-07 Janssen Pharmaceutica Nv Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists
EA019048B1 (en) 2008-07-31 2013-12-30 Янссен Фармацевтика Нв Piperazin-1-yl-trifluoromethyl-substituted pyridines as fast dissociating dopamine 2 receptor antagonists

Also Published As

Publication number Publication date
BG27543A3 (en) 1979-11-12
AU1787876A (en) 1978-03-23
PH12497A (en) 1979-04-05
ES451768A1 (en) 1978-05-01
NO147672C (en) 1983-05-25
GB1539473A (en) 1979-01-31
IE43802B1 (en) 1981-06-03
RO70079A (en) 1982-10-26
FR2325377A1 (en) 1977-04-22
CA1068271A (en) 1979-12-18
PL192578A1 (en) 1979-02-26
DE2642856C2 (en) 1990-06-21
DK150478C (en) 1987-10-05
PT65631A (en) 1976-10-01
GR58469B (en) 1977-10-14
DK427876A (en) 1977-03-24
NZ181972A (en) 1978-07-28
JPS5239683A (en) 1977-03-28
IL50522A0 (en) 1976-11-30
DE2642856A1 (en) 1977-03-24
FI61482B (en) 1982-04-30
NO763054L (en) 1977-03-24
NO147672B (en) 1983-02-14
AT363935B (en) 1981-09-10
NL187267B (en) 1991-03-01
IL50522A (en) 1979-09-30
YU39973B (en) 1985-06-30
ATA702976A (en) 1981-02-15
NL187267C (en) 1991-08-01
LU75837A1 (en) 1977-05-04
SE7610501L (en) 1977-03-24
IE43802L (en) 1977-03-23
SU747424A3 (en) 1980-07-23
PL117323B1 (en) 1981-07-31
SE427839B (en) 1983-05-09
HU172964B (en) 1979-01-28
PT65631B (en) 1978-07-05
CS222663B2 (en) 1983-07-29
CH628623A5 (en) 1982-03-15
YU233676A (en) 1983-01-21
IT1073893B (en) 1985-04-17
NL7610513A (en) 1977-03-25
FR2325377B1 (en) 1980-04-18
AU510029B2 (en) 1980-06-05
JPS6016417B2 (en) 1985-04-25
FI61482C (en) 1982-08-10
FI762698A (en) 1977-03-24

Similar Documents

Publication Publication Date Title
FI61481C (en) FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC THERAPEUTIC PIPERIDINDERIVAT
US4126689A (en) N-aryl-n-(1-alkyl-4-piperidinyl)-arylacetamides
JP3073238B2 (en) 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives
NO851393L (en) PROCEDURE FOR THE PREPARATION OF N-ARYL-N- (4-PIPERIDINYL) AMIDER.
IL124640A (en) 1-(1, 2-disubstituted piperidinyl) -4-substituted piperidine derivatives, a process for their preparation and pharmaceutical compositions comprising them
JP3056321B2 (en) Piperidine derivative
CZ68498A3 (en) Derivative of 4-(oxyalkoxyphenyl)-3-oxypiperidine, process of its preparation, intermediate for its preparation and pharmaceutical composition containing thereof
EP1180513A1 (en) Cyclic amide compounds, process for the preparation of the same and uses thereof
DK150478B (en) METHOD OF ANALOGY FOR THE PREPARATION OF N-ARYL-N- (4-PIPERIDYL) -ARYLACETAMIDE DERIVATIVES
EP0034415B1 (en) 1-(cyclohexyl or cyclohexenyl)-4-aryl-4-piperidinecarboxylic acid derivatives
US4292321A (en) 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof
US3041344A (en) 1-(aroylalkyl)-4-piperidinecarboxamides
WO2007114902A2 (en) Alkylthiobenzylpiperidine compounds
US4197304A (en) N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
HU182941B (en) Process for preparing new n-oxacyclyl-alkyl-piperidines further pharmaceutical compositions containing these compounds
US20040229864A1 (en) Sulfone derivatives as 5-HT7 receptor ligands
US4411904A (en) Diphenylpropanamines, compositions thereof and use thereof
US4151286A (en) N-aryl-N-(1-L-4-piperidinyl)-arylacetamides
US4197303A (en) N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
US4364954A (en) Diphenylpropanamines, compositions thereof and use thereof
KR840002022B1 (en) Process for preparing 1-(cyclohexyl)-4-aryl-4-piperidine carboxylic acid derivatives
US4208418A (en) N-Aryl-N-(1-alkyl-4-piperidinyl)arylacetamides
US4198411A (en) N-aryl-N-(1-L-4-piperidinyl)-arylaceytamides
US3481935A (en) 1-substituted-aminoloweralkyl-4-substituted-phenyl-piperidines
DK153474B (en) Analogy method for preparation of N-aryl-N-(4-piperidyl)- arylacetamide derivatives